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Essential oils (EOs) are natural antimicrobials that can be used to develop 
intervention strategies to inhibit pathogens, but EOs are lipophilic. Colloidal systems, 
such as microemulsions, are needed for food industry applications. This dissertation 
focused on the development and characterization of a microemulsion composed of 
cinnamon oil (CO, Cinnamomum zeylanicum) and orange oil (OO, Citrus sinensis) to be 
used against Salmonella Enteritidis H4267 biofilms formed on stainless steel disc 
surfaces. 
First, the antimicrobial activity of CO and OO against S. Enteritidis H4267, either 
used in combination or in a microemulsion system, was determined. CO had a greater 
antimicrobial effect on S. Enteritidis H4267 when used in combination with OO than 
when individually (p<0.001). The minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) indicated that CO and OO were optimum in 
a 9:1 volume ratio (MIC and MBC: 750:750 ppm). Physical analyses determined that 
formulations with, on mass basis, 0% and 2% sunflower lecithin (SL), 20% Tween® 20, 
1% and 5% CO-OO (9:1) were transparent, thermodynamically stable microemulsions 
that had bactericidal activity on S. Enteritidis H4267.  
The second objective investigated the biofilm forming ability of S. Enteritidis 
H4267 and determined a method to remove biofilms on stainless steel disc surfaces. S. 
Enteritidis H4267 was determined to produce curli and cellulose indicative of biofilm 
development, and biofilms were formed on stainless steel disc surfaces. Sonication in 
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0.1% (w/v) peptone water for 30 sec effectively dislodged biofilms from disc surfaces 
without causing extensive cell death.  
Biofilms were treated with microemulsions and emulsion controls for 5 minutes 
to determine the antimicrobial activity in the third objective. The 2% SL, 5% CO-OO 
(9:1) microemulsions displayed the greatest antimicrobial activity against biofilms.    
This study demonstrated that OO enhances the bactericidal activity of CO when in 
an oil or microemulsion system, and co-encapsulated oils in microemulsions could be 
developed for antimicrobial delivery systems. Further research into developing 
microemulsions with positively charged droplets and with greater microemulsion 
exposure time should be investigated.  
 
Keywords: microemulsions, essential oils, antimicrobial delivery system, Salmonella, 
biofilms, stainless steel  
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Chapter 1. Introduction and objectives 
 
1. Introduction 
 Of the 48 million cases of foodborne illness that occur in the US annually, only 
9.4 million cases are related to a foodborne pathogen that has an identified pathogen 
source.1-2 Non-typhoidal Salmonella is the leading bacterial cause of foodborne illness, 
and the rates of Salmonella cases in the US have remained relatively constant with 
approximately 1 million illnesses, 19,000 hospitalizations, and 380 deaths annually.3-6 
These numbers are estimated to be lower than actual infection rates since foodborne 
illness cases are often underreported as symptoms can be commonly be referred to as 
“stomach flu-like” symptoms.7-8  
Since 2005, over 35 foodborne illness outbreaks in the US have been traced back 
to Salmonella species (spp.).9 Poultry, egg sources, and fresh fruit has contributed 50% 
(1653 cases) of US food-related cases from 2015 to 2019.9 S. enterica subspecies (subsp.) 
enterica serovar Enteritidis (S. Enteritidis) is the leading Salmonellae isolate serotyped 
from laboratory-confirmed cases of foodborne infection.10 Between 2007 and 2015, the 
incidence of infection from S. Enteritidis increased by 37%.10-11 
With non-typhoidal Salmonella resulting in approximately 380 deaths a year in 
the U.S., decreasing the rates of Salmonella spp. in the food supply is a priority.12 In the 
U.S., the economic impact of salmonellosis, the gastrointestinal disease associated with 
Salmonella, can be as high as $10.9 billion per year, and the cost of illness is estimated at 
over $3.3 million per year.4, 13-14 While bacterial presence in the food industry is of 
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concern and can cause foodborne illness, the majority of bacterial life is thought to exist 
in biofilms.15 
Biofilms are a composition of a microorganism or microorganisms attached to a 
surface that are encased within an extracellular polymeric substance (EPS) layer.16-20 The 
formation of a biofilm is complex and consists of a variety of intrinsic and extrinsic 
components. Biofilm formation generally consists of five stages: reversible attachment, 
irreversible attachment, proliferation, maturation, and detachment.19 The ability to 
convert to being immobile instead of planktonic depends on a variety of environmental 
factors, and once attached, organisms must be able to convert to being irreversibly 
attached while proliferating within a biofilm.19, 21 As biofilms mature further and 
proliferation of microorganisms continues, an increase in biomass occurs within the 
biofilm. As biofilms become larger, pieces of biofilms can detach from the biofilm 
structure.22 
Biofilms can form on practically any surface, and the ubiquitous nature of 
biofilms is troubling for the food industry.23-26 If an antimicrobial delivery system were to 
diffuse through the EPS layer and/or become internalized into the biofilm, the system 
would be advantageous to a variety of industries. Antimicrobial delivery systems to 
combat biofilms in the food industry while also avoiding bacterial resistance to 
disinfectants are of interest.27 Plant-derived essential oils (EOs) are an attractive option 
for antimicrobial systems since EOs do not contribute to drug resistance due to the 
current mechanism of action focusing on the disruption of bacterial membranes.28-31 The 
hydrophobicity of EOs also requires colloidal systems, such as emulsions, for utilization. 
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 Colloidal systems with nanoscale oil droplets have unique features uncommon in 
conventional emulsions.32-33 Nanoemulsions have a droplet diameter between 20 and 200 
nm, and microemulsions have an oil droplet dimension between 4 and 100 nm.32 Though 
microemulsions have a small droplet size, they are relatively easy to prepare in 
comparison to some emulsions.34 Microemulsions have the added benefit of being 
transparent and thermodynamically stable oil-water-surfactant mixtures while 
nanoemulsions are metastable systems that can be clear or turbid in appearance.32, 35 
Microemulsions also have the ability to enable EO compounds to penetrate through 
bacterial cell walls more efficiently due to their small droplet size and large surface area, 
which can increase the antimicrobial activity.36 While there are several benefits of 
microemulsions, microemulsions are formed only at a particular set of conditions, such as 
environmental conditions and composition, and may convert to a different colloidal 
system when the conditions are changed.32-33 Microemulsions also require a high level of 
surfactants.32 Despite these drawbacks, microemulsions can be used to deliver lipophilic 
compounds, such as EOs, which could be an approach to enhance antimicrobial activity. 
37-38 
EOs are an attractive option for antimicrobial systems due to the hydrophobicity 
of EOs allowing the oil to penetrate through the bacterial cell membrane, which can 
destabilize the membrane structure.29-30 The destabilization of the membrane structure 
causes disruption of the cell’s metabolic processes and membrane transport systems, 
which ultimately leads to the breakdown of membrane integrity.29-30 As the membrane 
integrity declines, the increased membrane permeability occurs, which ultimately leads to 
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cell death.29 When combined with other organic compounds, the antimicrobial activity of 
the individual EOs may be enhanced to provide greater antimicrobial ability at reduced 
levels.39 Cinnamon oil (CO, Cinnamomum zeylanicum) has been extensively researched 
as an antimicrobial against a variety of foodborne pathogens, including S. Enteritidis.40-43 
Orange oils (OO, Citrus sinensis) have exhibited inhibitory activity against a variety of S. 
enterica and have displayed antimicrobial activity enhancement of other EOs when used 
in combination against Salmonella spp.44-45  
CO and OO have been investigated individually for antimicrobial activity against 
foodborne pathogens, but the possible synergy in antimicrobial activity of CO and OO in 
combination has not been studied. Microemulsions containing co-encapsulation of EOs 
with an antimicrobial compound, antibiotics, and coenzyme Q10 have been created, so an 
antimicrobial delivery system containing co-encapsulated CO and OO could also be 
created.37-38, 46 Internalization of an emulsion-based system with droplet sizes near the 
microemulsion range in Pseudomonas aeruginosa biofilms have confirmed that 
nanoscale oil droplets have the ability to penetrate a biofilm’s EPS layer.47 The developed 
microemulsion containing CO and OO could be utilized as an antimicrobial delivery 
system for S. Enteritidis biofilms. 
 
2. Research objectives 
The goal of this dissertation was to develop an antimicrobial delivery system in 
the form of a microemulsion containing co-encapsulated CO and OO. To develop this 
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microemulsion system and determine if it has antimicrobial activity against a biofilm, the 
following three objectives were developed. 
  
2.1. Objective I: Antimicrobial inhibition of Salmonella Enteritidis H4267 via 
cinnamon and orange oil used in neat form, in combination, or in a microemulsion 
system.  
The first objective was divided into three phases. The first phase aimed to 
determine the antimicrobial ability of the selected EOs, CO and OO, prior to the 
development of a microemulsion containing the oils. The first phase’s hypothesis was 
that CO and OO will have inhibitory activity against planktonic S. Enteritidis H4267 
when used in combination. This is supported by OO’s ability to enhance the antimicrobial 
activity of other EOs when used in combination against Salmonella sp. and CO’s 
bactericidal activity against S. Enteritidis alone and in combination with other EOs.42, 44-45  
The second phase was to develop a microemulsion formulation for encapsulation 
of CO and OO, and upon microemulsion creation, physical characteristics were 
investigated. The second phase hypothesis was that through the adjustment of surfactant 
and oil levels, a microemulsion containing CO and OO can be formed. Microemulsions 
of oil mixtures have been created and characterized previously.37-38  
The third phase investigated the antimicrobial activity of the microemulsion 
systems formed during Objective I, Phase 2 against S. Enteritidis H4267. Surfactants can 
lower the antimicrobial ability of an emulsion system, but EOs can still have an 
antimicrobial effect in emulsion systems despite the surfactant addition.48-53 The 
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hypothesis for the third phase was that microemulsions containing CO and OO would 
have antimicrobial activity against S. Enteritidis H4267. 
 
2.2. Objective II: Development and characterization of Salmonella Enteritidis H4267 
biofilms.  
Objective II was split into two phases to investigate the characterization of 
biofilm development and the removal method for biofilms formed on stainless steel discs. 
Since there is no current literature on the development and characterization of S. 
Enteritidis H4267 biofilms, phase one aimed to address this lack of knowledge. The 
occurrence of curli and cellulose production was determined via Congo Red agar and 
Luria Broth agar supplemented with 0.02% (w/v) calcofluor as well as the development 
of the biofilm in a microtiter assay. Staining with crystal violet allows for both visual 
observation as well as a quantitative analysis of biofilm extent. The hypothesis for phase 
one was that S. Enteritidis H4267 can form biofilms. Previous work indicating that 
Salmonella biofilm phenotypes display curli and cellulose production supports the 
hypothesis.54-56 
The second phase of Objective II focused on the development of S. Enteritidis 
H4267 biofilms on stainless steel disc surfaces. S. Enteritidis H4267 was hypothesized to 
form biofilms on stainless steel disc surfaces due to previously reported formation of 




2.3. Objective III: Determination and characterization of the antimicrobial activity of 
microemulsions containing cinnamon oil and orange oil on S. Enteritidis H4267 
biofilms formed on stainless steel disc surfaces.  
Due to the complexity of biofilms, microemulsions that have activity against 
planktonic cultures may not have activity against a formed biofilm. Additionally, droplet 
size is of importance for biofilm treatment to determine if a microemulsion would also be 
able to have an antimicrobial effect on biofilms. The goal of Objective III was to 
determine if the CO and OO microemulsions developed for Objective I have 
antimicrobial activity on S. Enteritidis H4267 biofilms on the stainless steel surface 
utilized in Objective II. The hypothesis was that microemulsions containing high volumes 
of CO and OO will have a greater antimicrobial effect on S. Enteritidis H4267 biofilms 
compared to control emulsions of a larger droplet size. Because of the small droplet size, 
microemulsions should have greater bioavailability and could have higher antimicrobial 
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Chapter 2. Literature review 
 
1. Foodborne illness 
Annually in the United States, an estimated 48 million cases of foodborne 
illnesses occur, but only 9.4 million foodborne illness-related cases have an identified 
pathogen source.1-2 Foodborne illness cases are often underreported as symptoms can be 
commonly be referred to as “stomach flu” and symptoms include nausea, vomiting, 
diarrhea, and/or fever.3-4 Being unsure of the cause, having a belief that reporting would 
not be beneficial, and the amount of time between consumption of the food and reporting 
are all causes for the underreporting of foodborne illnesses.4 The 9.4 million cases that 
are identified annually result in over 56,000 hospitalizations and 1,400 deaths.5 Reducing 
these case numbers is not only of public health concern, but also of economic interest as 
it was estimated in 2015 that the economic burden of foodborne illnesses was over $15.5 
billion.6  
Of the top five causes of foodborne illnesses, non-typhoidal Salmonella is the 
leading bacterial culprit.5, 7 Non-typhoidal Salmonella species are estimated to be the 
cause of approximately 1 million foodborne illnesses, 19,000 hospitalizations, and 380 
deaths in the US annually.8 In 2012, it was estimated that Salmonella-related foodborne 
illness resulted in $10.9 billion in losses due to medical need, productivity loss, and 
mortality costs.8 Among the human Salmonella isolates reported in the US, 99% belong 
to S. enterica with the top two S. enterica isolates serotyped from laboratory-confirmed 
cases being S. Enteritidis and S. Typhimurium.9 Between 2007 and 2015, the incidence of 
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infection from S. Enteritidis increased by 37% while S. Typhimurium incidence of 
infection decreased by 66%.9, 10  
 
1.1.  Intervention methods  
The high costs associated with foodborne outbreaks, particularly with pathogenic 
bacteria, are of great concern for food industries and government agencies.6, 8, 11 The 
persistence of bacteria and issues with bacterial removal once in a food processing 
environment necessitates the need for preventive measures in food facilities.11 
Government regulation requires the implementation of food safety preventive measures, 
such as Good Manufacturing Practices (GMPs), Hazard Analysis and Critical Control 
Points (HACCP), and items detailed in the Food Safety Modernization Act (FSMA).12-15   
A facility’s GMPs requires companies to abide by sanitation practices that keep 
employees trained and proper equipment and facility maintenance to be performed.13  
Testing methods must also be performed regularly to decrease the likelihood of sanitation 
issues.12-13 HACCP systems must also be implemented to identify and target control 
points in the food processing chain to be monitored by sampling.14 Accurate record 
keeping is utilized to maintain accountability and ensure sanitation methods are 
efficient.14 The passage of the FSMA provided updates to HACCP requirements. In 
addition to having hazard identification conducted and a preventive control plan being 
created, facilities were required to provide a supply chain program hazard analysis.15 If a 
hazard from a manufacturer requires a preventive control and the control will be applied 
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in a facility’s supply chain, manufacturers are responsible for ensuring that suppliers are 
approved.15  
Process flow and equipment design can also play a role in cleaning design and 
preventing contamination. Ensuring adequate space between processing lines and defined 
areas between raw and finished product assists with minimizing contamination.16-17 Easy 
access points for equipment can also assist with ensuring proper sanitation and cleaning 
of material surfaces.17 Clean-in-place (CIP) systems for equipment assists in not only 
providing a cleaning routine but also increasing employee safety by having an enclosed 
sanitation system that utilizes chemical agents.16, 18 A concern with CIP systems is that 
bacteria can be detached from surfaces early in the cleaning system but could reattach to 
a surface further in the system line.18  
Sanitizing and cleaning agents, such as hypochlorite, peroxygens, acids, and 
quaternary ammonium compounds, are commonly used in the food industry to ensure 
facility and CIP system cleanliness.19 The antimicrobial effect of organic acids results 
from their ability to lower pH and from the toxicity to microorganisms from the 
undissociated form of the acid.20-21 All microorganisms have a maximum, minimum, and 
optimum pH level for growth, and if pH is changed, it can influence the inhibition or 
growth of the organism.21 Undissociated acid molecules can easily cross cell membranes 
of microbial cells and enter the cytoplasm, where the molecules will dissociate due to the 
cytoplasm pH being more than 6.0.20 As a result, the cytoplasm pH will be lowered, 
causing the cell to use energy to force excess hydroniums out of the cytoplasm to regain 
metabolic pH.20 Eventually, the cytoplasm pH falls below the level of cell homeostasis, 
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and the cell dies.20  While several chemical antimicrobials are available, the presence of 
organic material can decrease the antimicrobial efficacy of wash solutions.16-17  
 
2. Salmonella 
2.1. Characteristics of Salmonella enterica 
Salmonella species (spp.) are rod-shaped bacteria that are facultatively 
anaerobic.16, 22 Belonging to the family Enterobacteriaceae, Salmonella are also Gram-
negative, non-sporulating organisms.23 Salmonella grows optimally at 37°C but can also 
proliferate at temperatures between 5.3°C and 45°C.16 The optimum pH for growth is 
near neutral pH at pH 6.5–7.5, but growth for Salmonella has been recorded in pH as low 
as 4.05.22, 24 Water activity (aw) levels must also be at or above 0.94 for growth, with 
higher aw values being required as the pH decreases, although this is dependent on the 
environment.16 While Salmonella spp. can catabolize glucose, which results in acid and 
gas production, the bacterium cannot utilize lactose as a carbohydrate source.22   
 In the genus Salmonella, there exists two species: S. bongori and S. enterica. S. 
enterica can be further classified into six subspecies (subsp.), including enterica, 
arizonae, diarizonae, salamae, houtenae, and indica.16 Although there are a myriad of 
Salmonella spp. S. enterica subsp. enterica is usually associated with warm-blooded 
mammals, and 99% of Salmonella-related human infections can be attributed to this 
particular group of Salmonellae.25 The S. enterica subsp. enterica contains over 1,500 
serovars and establishes the concept that Salmonella can adapt to a variety of ecologically 
diverse environments to survive.22, 25 Cold shock proteins are used by Salmonella to adapt  
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to low-temperature environments while certain strains, such as S. Seftenberg strain 
775W, have high thermotolerance with low water activity.26 Most Salmonella spp. are 
motile with peritrichous flagella, but S. enterica subsp. enterica serovar Pullorum and S. 
enterica subsp. enterica serovar Gallinarum are non-motile strains due to the lack of 
functional flagella.22, 27 
 
2.2. Salmonella and foodborne illness 
The primary environment for Salmonella spp. is in the intestinal tract of animals, 
such as birds, reptiles, humans, and farm animals, with humans and animals being the 
primary reservoirs.16 Salmonella can be excreted via fecal matter, and this can result in 
transmission to humans by insects and other living creatures serving as vectors.28 
Animals can serve as a vector when Salmonella is present in the gastrointestinal tract and 
are excreted in the animal’s feces, resulting in an unsanitary environment.29 Salmonella 
can also be present on the exterior surface of an animal, and contamination can occur 
when contact is made with fecal matter.16  As humans and other animals consume 
contaminated foods and water, and the organisms are shed through fecal matter, the cycle 
will continue.28-29 Through these dissemination vehicles, Salmonella spp. can eventually 
be found in water, soils, and farms, resulting in their presence on food commodities 
through cross-contamination and natural occurrence.16, 29 
Since 2015, Salmonella spp. have been the source of over 35 foodborne illness 
outbreaks in the US.30 Over 26% of Salmonella cases from 2015 were traced back to fruit 
sources, such as papayas, cut fruit, and dried coconut.30 Poultry and egg sources, such as 
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ground turkey and shell eggs, were the next leading cause of Salmonella cases during this 
time with over 23% of Salmonella cases.30 Together, these food categories had 1653 
cases, 557 hospitalizations, and 6 deaths attributed to Salmonella infection and made up 
50% of Salmonella food-related cases from 2015 to 2019.30  
 
2.2.1. Salmonellosis 
Salmonellosis is a gastrointestinal disease that typically lasts 4–7 days, although 
chronic salmonellosis can occur.31-32 Salmonella infections can occur in humans when as 
few as 10 cells per gram are present.16 Rates of salmonellosis are the highest from May 
through October.33 This may be due to the increased occurrence of temperature abused 
foods and/or cross-contamination of foods at cookouts during the summer months.29 
However, the more likely cause is that higher ambient temperatures provide an 
environment suited for rapid bacterial replication.34 Children under the age of 5, older 
adults, and immunocompromised individuals are at the highest risk for infection, 
requiring the consumption of fewer cells in order to develop symptoms.16, 29, 35 
 Symptoms for salmonellosis can appear in as few as 4 hours, but the average 
incubation period until the onset of clinical illness is regarded as 12-14 hours.16, 32 
Salmonellosis can cause lower gastrointestinal tract symptoms within an infected 
person.16, 32 These symptoms can include abdominal cramps, diarrhea, vomiting, fever, 
chills, nausea, and a possible headache.28, 30 Most individuals recover without needing 
antibiotic treatment, but in severe cases, Salmonella can infect the bloodstream or other 
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parts of the body.31 Severe cases result in an individual needing medical attention, and 
death can occur if the disease is not treated.35 
 Although salmonellosis has been causing illness for over 125 years, it has only 
been a notifiable disease in the U.S. since 1942.29, 35 While it is mandatory that reportable 
disease cases are reported to the state and territorial jurisdictions, it is voluntary that 
notifiable diseases are reported to the CDC by state and territorial jurisdictions.36 Since 
1942, the rate of reported cases for salmonellosis has increased over time, but this could 
be attributed to more awareness, surveillance, and sampling.29, 35 Recently, rates of 
Salmonella cases have remained relatively constant, with approximately 1 million 
confirmed Salmonella-derived foodborne illnesses occurring per year in the U.S.37 With 
non-typhoidal Salmonella resulting in an annual estimate of 378 deaths a year in the U.S., 
decreasing the rates of Salmonella spp. in the food supply is a priority.38 This is a priority 
not only due to the hospitalizations and/or fatalities that may occur, but also due to the 
economic impact that salmonellosis can have annually.39 In the U.S., the economic 
impact of salmonellosis can be as high as $10.9 billion per year, and the cost of illness is 
estimated at over $3.3 million per year.8, 31, 40  
 
3. Biofilms 
The first indication possibly describing biofilms was when cell aggregates were 
seen during dental plaque examinations by Anton von Leeuwenhoek.41-44 Some claim that 
Henrici accurately recorded biofilms when observing bacteria that were able to grow on 
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submerged surfaces in water.45 Regardless of the initial discovery, biofilms have since 
been described in a variety of environments outside of an oral cavity and freshwater.45-48  
The name “biofilm” was established by Bill Costerton in 1978.41, 46 A basic 
description is that biofilms are composed of microorganisms attached to either a surface 
or themselves with an extracellular polymeric substance (EPS) layer, and sessile cells 
contained within biofilms are different from planktonic cells.43, 49-52 Since biofilms have 
been seen in a variety of environments, specific definitions of biofilms vary minutely 
across foci, but the general concept remains as described.  
 
3.1. Ability of microorganisms to form biofilms 
Organisms must synergize with other organisms, sometimes of other species and 
phyla, with success to survive.53-54 The production of EPS is an example of how 
individual cells can coordinate to work in communities. However, methods of 
intracellular communication for microorganism community building have been debated 
due to the complexity of the biofilm interior.53-55  
There are methods of cell communication, such as quorum sensing, chemotaxis or 
release of extracellular DNA, which do not rely solely on EPS. Quorum sensing was first 
described when Vibrio fisheri was observed secreting autoinducer (AI) molecules.23, 56 
Autoinducer 2 (AI-2) is a quorum sensing signal that has been shown to stimulate biofilm 
formation.57-58 Cyclic-di-(3’-5’) guanylic acid (c-di-GMP) is a secondary messenger 
responsible for relaying environmental conditions intracellularly and is highly researched 
in S. Typhimurium.59-60 Extracellular DNA released from lysed cells within the biofilm 
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can be important for intracellular communication for certain organisms, such as 
Pseudomonas aeruginosa.61  The broad spectrum of cell communication systems 
strengthens the argument that these systems do not exclusively regulate biofilm 
development, but rather, biofilm development is a component that some cell 
communication systems contribute towards.53  
 
3.2. Biofilm development 
The formation of a biofilm is a complex process, consisting of a variety of 
intrinsic and extrinsic components. Changes in gene expression regulating motility 
appendages and EPS-producing compounds can assist in bacteria attaching to a surface.51 
The reduction of nutrient availability in the environment can also promote faster 
formation of biofilms for some organisms.62-63 Model systems of non-equilibrium, non-
living systems have been utilized to attempt to understand the formation and structure of 
biofilms.54, 64 While these model systems can be utilized, different systems yield differing 
results, and the complexities of biofilms cannot give consistent results, especially when a 
variety of species are taken into consideration.54 
 
3.2.1. Attachment 
Being able to convert from a planktonic to a sessile state is important for biofilm 
attachment success.41, 65-66 The ability to convert to being immobile instead of planktonic 
depends on a variety of environmental factors and can be dependent on the organism’s 
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ability to mediate attachment.51 The organisms must then be able to convert to being 
irreversibly attached and still be able to proliferate within the biofilm.67 
Attachment for bacteria is thought to be able to occur when an environmental 
condition, or combination of conditions, triggers planktonic bacterium to seek a sessile 
state.51, 68-71 Motility appendages, such as flagella, fimbriae, or pili, and surface protein 
presence can play a crucial role in biofilm formation, but may not be necessary 
depending on the environment.72-75 Bacterial cells can produce signals for a cell to use a 
glycocalyx structure to attach to a surface.46, 53 Cells can aggregate at the site of 
attachment using the organism’s motility mechanisms or via an aqueous flow in which 
the organisms are suspended.45 
Once attached, cells can either be reversibly or irreversibly attached.76 When cells 
are in the reversible attachment stage, bacteria are kept in place through a combination of 
steric, electrostatic, hydrophobic, and van der Waals interactions.77 Cells will frequently 
de- and re-attach during this stage through nearby shear forces, such as an aqueous 
flow.76-77 Cells can enter an irreversible attachment stage where cells form a surface 
monolayer and aggregate together to form a microcolony.51 The utilization of type IV pili 
to twitch or “crawl” across surfaces to form these microcolonies leads to successful 
biofilm formation.69, 78 The confirmation of irreversible attachment can also indicate 






3.2.2. Proliferation, maturation, and detachment 
Bacterial settlement can be determined as a “success” when cells adhere and are 
able to grow and cooperate metabolically in the biofilm community.67 Single- and 
multispecies presence can influence the proliferation of organisms contained within the 
biofilm, and fitness of the organism’s level of growth could be related to EPS producing 
ability.43, 79 As microorganisms proliferate, EPS are excreted, encasing the biofilm in a 
scaffolding matrix.80 During proliferation, cells within biofilms can function as 
cooperative groups by releasing extracellular signals to upregulate EPS production and 
other products.44, 60, 81 These byproducts assist in distinguishing between microcolonies 
within the biofilm community.60, 81   
Complexities within the extracellular matrix of the biofilm arise with continued 
proliferation leading to biofilm maturation. The ability to gain nutrients in a biofilm can 
be difficult as diffusion must be able to overcome biochemical and structural obstacles.82  
Once nutrients permeate a biofilm, bioavailability of nutrients to cells depends on 
successful diffusion past the exterior portion of the biofilm structure.83-84 As more EPS is 
produced, channels and pores begin to form within the biofilm, creating a highway for 
transporting water, oxygen, and nutrients throughout the biomass while excreting waste 
products from the interior portion.85-86  
 As biofilms mature further and proliferation of microorganisms continues, an 
increase in biomass occurs within the biofilm. Biofilms begin to take on a mushroom-like 
appearance as biomass accumulates and more channels begin to form.85 As biofilms 
become larger, pieces of biofilms can detach from the biofilm structure.42 Biofilm 
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detachment can occur via passive dispersal where shear stress from fluid flow in the 
environment can cause sections of the exterior portion of the biofilm to be removed from 
the main biofilm structure.82  It could be that there are also environmental cues for 
detachment from biofilms, such as chemical or physical gradient changes.42, 82, 87 Cells 
can additionally leave through channel or pore openings or revert to planktonic cells and 
disperse to repeat the biofilm process again.88  
 
3.3. Biofilm matrix 
The EPS can be described as a mass of polysaccharide fibers that extend outside 
of the surface of the bacteria and forms a glycocalyx around and between cells.46 It is 
considered one of the most crucial characteristics of bacterial biofilms as the EPS matrix 
acts as a means for direct and indirect cell interaction as well as protection.89 The EPS 
also provides protection from extrinsic forces and antimicrobials as well as creating the 
network of pores and channels for nutrient and oxygen supplies.86, 90 Microorganisms 
within biofilms utilize the EPS matrix to communicate with other cells and their 
environment, both the microenvironment and outer environment.89 The EPS matrix 
contains polysaccharides, proteins, lipids, nucleic acids, enzymes secreted from cells, and 
materials from the surrounding environment.91 This complex network enables the 
microbial success of a biofilm community. 
A major component of the EPS layer is polysaccharides. Cells utilize 
polysaccharides to adhere to the EPS matrix present on cell surfaces and onto substrate 
surfaces.90 Cellulose, an extracellular polysaccharide, is an indicative factor of bacterial 
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ability to form biofilms79, 90, 92 and is a major component of Salmonella biofilms.93 By 
interacting with curli present in an extracellular matrix, cellulose can provide structure 
and support cell adhesion.93 In addition to biofilms being more resistant to antimicrobials, 
cellulose presence can provide resistance to chlorine treatment against Salmonella 
serovars.94  
O-antigen polysaccharide is another extracellular polysaccharide that can be 
produced by Salmonella to assist with biofilm development.94 O-antigen polysaccharide 
provides Salmonella spp. biofilms with the ability to persist through desiccation stress 
and sublethal injury.94 The utilization of both cellulose and O-antigen has been shown to 
enable Salmonella to attach and form biofilms on plants and plant food products.95 
 
3.4. Biofilms in food processing environments 
Food processing environments are ideal environments for microorganisms due to 
the large volume of water usage, constant food matter available to serve as nutrient 
sources, and high number of human personnel involved.16 The large variety of equipment 
surfaces, material types, and drains and pipes present in a food processing facility are 
perfect harbor points for bacterial growth.16, 96 If cleaning, sanitation, and hygienic 
practices are not implemented correctly, microorganisms can thrive in food processing 
environments.16, 97 Additionally, biofilms present in a food processing facility can allow 
for a persistent pathogen source with detachment allowing for microorganisms to travel 
throughout a facility.98-100 Eventually, food products, materials, and contact and non-
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contact surfaces can become contaminated, leading to large scale effects, such as food 
recalls and plant closures.97-100  
 
3.4.1. Material surfaces   
Equipment and devices used in the food industry can vary from personal 
protective equipment to water-wash tanks used to clean produce.16 Stainless steel, 
aluminum, polypropylene, rubber, silicone and other materials are commonly used in the 
food industry.79, 101 Metals, such as stainless steel, aluminum, copper and tin, are 
commonly used throughout a variety of food industries.102 While glass is one of the most 
commonly used materials in the food industry, metal and plastics are more common, with 
metals being the most important material used in food processing equipment.102  
The type of bacterial species can affect the surface they attach to. 42, 67 In the 
mouth, only teeth, epithelial mucosa and the newly formed surface on growing dental 
plaques act as available surfaces, so organisms must be able to adapt and attach to the 
surfaces made available in the environment.67  While the function of devices and 
equipment used in the food and healthcare industries differ, the materials utilized to 
create these machines and tools are similar.47, 101  
Stainless steel is utilized for manufacturing a major component of most 
processing equipment.17 The food industry uses stainless steel austenitic grades 304 and 
316 the most due to the ease of cleaning, high temperature stability, and resistance to 
corrosion.17 Steel surfaces can also be finished differently, such as via cold rolling or 
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electro-polished.103 The more polished or finished and smooth a surface, the less likely 
bacteria will be able to attach and colonize the surface.103-104  
Surface roughness, a characteristic based on the distance between peaks and 
valleys present on a material’s surface, can also cause increased opportunity for biofilms 
to form.16, 104-105 Crevices present in rough surfaces provide bacteria with harborage 
points.105-106 These crevices can increase the likelihood of bacterial attachment to occur 
and colonize surfaces.66, 107 Deterioration of equipment surfaces can cause biofouling and 
can also harbor bacteria.108 With rigorous cleaning protocols and continued mechanical 
abrasion, food processing equipment surfaces become more rough over time.19  
Prolonged bacterial presence could affect the equipment surface as well, causing 
corrosion or increased porosity. Biofilms can also contribute to surface corrosion since 
some bacteria can produce acid that can corrode equipment surfaces.109  
The surface charge of materials can also contribute to bacterial attachment.101, 105 
Depending on the surface material, the negatively-charged bacterial surface can be 
repelled. Metals are negatively charged at the surface and hydrophilic.107, 110 Teflon-
coated surfaces are hydrophobic due to having a lower electrostatic-charge.105, 110 Surface 
hydrophobicity can be correlated to contact angle, with hydrophobic surface contact 
angles above 90° being favorable for prevention of fluid pooling.111 There are some 
exceptions, such as Listeria monocytogenes being able to attach to a variety of material 
surfaces, whether the materials are hydrophobic or not.101, 112 Though there is evidence 
that charges can cause attraction or repulsion towards bacterial attachment, a study by 
Baker113 showed that materials, such as polystyrene or hydrophilic glass, show no 
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statistical difference on attachment rates. Since this study, food processing equipment has 
advanced, leading food engineers to develop equipment that would be less likely to 
harbor bacteria.114  
 
3.4.2. Treatment 
While advancements towards equipment surfaces have been made, surface contact 
interventions, such as the application of a Teflon film, are not enough to be a standalone 
prevention of biofilms in the food industry.115 When food matter is present, antimicrobial 
coated surfaces can still harbor bacterial growth and attachment.115 If improper cleaning 
and sanitization occurs, microorganisms can seize the opportunity to utilize secure 
attachment to equipment and facility surfaces, and proliferation can occur due to the high 
nutrient availability that was not removed in routine cleanup.16, 105, 108  
Treatment must be preventive instead of proactive. A combination of antimicrobial 
interventions are utilized to create a hurdle effect, with the premise being that with each 
hurdle applied against the organism, bacterial fitness in the environment decreases.16 
Common intervention practices include (i) mechanical action, such as scraping or 
sonication, (ii) chemical intervention, seen in the use of quaternary ammonium 
compounds or membrane-disrupting sanitizers, and/or (iii) thermal intervention which 
can be the use of chemical interventions in combination with high water temperatures or 
the removal of heat during freezing processes.16, 105, 108 An industry lacking in these areas 
could cause microorganism growth to progress to the point where bacterial contamination 
of the food can occur.108  
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Increased sanitization and medicinal resistance is also a characteristic of biofilms.41, 
44, 116 Sessile cells contained within a biofilm can become more resistant to sanitizing or 
antimicrobial methods than their planktonic counterparts.79, 101, 117-118 Microorganisms 
within biofilms can proliferate at a slower rate than their planktonic counterparts.50 Due 
to the decreased metabolism, increased resistance towards antibiotics or bactericidal 
interventions can occur.41 Permeability through the complex biofilm matrix could also be 
related to the amount of biofilm biomass density; the higher the cell density, the lower the 
diffusion.41, 64, 119   
The ability of bacteria to utilize efflux pumps for transport of antibiotics out of the 
cell and to maintain homeostasis of chemical gradients are critical towards preventing 
cell death.41, 47 Successful treatment of bacterial biofilms can also be strain-dependent. 
When comparing various strains of S. Typhimurium and Escherichia coli O157:H7, EPS-
producing strains in biofilms had higher resistance to quaternary ammonium compounds 
and chlorine sanitizing solutions compared to planktonic cells.79 Multispecies biofilms 
can also contribute to developing an increased antimicrobial or sanitizer resistance in 
bacteria that have low biofilm-forming ability.79 Low- to no-curli and cellulose producing 
S. Typhimurium and E. coli O157:H7 strains were able to have higher sanitizer resistance 
in multispecies biofilms compared to single-species biofilms of the same strains.79 
Methods for antimicrobial and sanitizer resistance also vary and are dependent upon the 
antibiotic or sanitizer type, the species, or the environment.41 Since biofilms can be 
diverse and dependent on the environment and presence of other microorganisms, the 





Food emulsions are complex systems composed of two immiscible liquids, and 
fall within the realm of colloidal systems consisting of oil droplets distributed within a 
liquid medium.120-122 An oil-in-water (O/W) emulsion will occur when the oil fraction 
occupies the dispersed phase.123-124 Oil can also occupy the continuous phase and water-
in-oil (W/O) emulsions will form.123-124 Most emulsions are O/W or W/O, but there are 
complex multiple emulsions that can be oil-in-water-in-oil (O/W/O), water-in-oil-in-
water (W/O/W), and solid-in-oil-in-water (S/O/W) combinations.122  
 
4.1. Types of emulsions 
Emulsions are commonly classified based on droplet size. Food emulsions are 
generally in the micrometer (µm) droplet diameter range, while nanoemulsions and 
microemulsions have droplets with a diameter being in the nanometer (nm) range.125-128 
Emulsions can also be distinguished from one another based on thermodynamic stability 
and structure.129 
 
4.2. Distinguishing between nano- and microemulsions 
There are discrepancies about the droplet size of microemulsions, and the 
definition has been redefined several times.124 Mason130 and McClements120, 129 both state 
that the main difference between the two are that nanoemulsions are metastable with high 
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interfacial tension present whereas microemulsions are thermodynamically stable and 
have extremely low interfacial tension.  
4.2.1. Droplet size distribution 
Droplet size can determine emulsion properties, such as appearance and 
stability.131 Emulsions that have droplets of only one size are described as monodisperse 
whereas polydisperse describes emulsions with droplets that have a range of sizes.132 For 
droplet size distribution, histograms of volume frequency demonstrating size-class of 
droplets are often utilized.133 A common method of determining mean droplet size for an 
emulsion is by determining the area-volume mean diameter (Equation 1.1) where ni is 









The overlapping size areas for nano- and microemulsions have caused some 
confusion. McClements123 describes the droplet radius of emulsions, nanoemulsions and 
microemulsions to be from 100 nm – 100 µm, 10-100 nm, and 2-50 nm, respectively. 
Sanchez-Dominguez135 agrees with McClements’ size cutoff, but Narang136 categorizes 
microemulsions droplet radii to be below 200 nm. It is important to take droplet size into 
consideration along with thermodynamic stability to determine whether a formulation is a 
microemulsion.  
 




Droplets in nanoemulsions are not thermodynamically stable while those in 
microemulsions are stable.130 While large droplets can cause emulsions to be opaque, 
nanoemulsions can also be translucent.130 The droplet size in nanoemulsions can be small 
enough that droplets smaller than optical wavelengths cannot refract light.130 Over time, 
nanoemulsions can break down due to coalescence, flocculation, or Ostwald ripening.137 
The rate of nanoemulsion breakdown depends on a variety of factors, such as oil and 
surfactant type and temperature.120   
Microemulsions are thermodynamically stable and transparent.138 Surfactant 
molecules within O/W microemulsions are highly organized, and non-polar surfactant 
tails associate closely with each other to form a hydrophobic core capable of dissolving 
nonpolar components.120 This requires high concentrations of surfactant to be used for 
microemulsions to ensure there are enough surfactant molecules to promote these highly 
organized micelles.120, 129 The free energy associated with the colloidal dispersion of oil 
droplets in water must be lower than the free energy of the separate, individual oil and 
water phase to create a thermodynamically stable microemulsion.120 However, a 
microemulsion is only thermodynamically stable under a particular set of conditions, 
such as temperature and surfactant concentration, and mechanical and/or thermal energy 
may be required to reduce the energy barrier in a formulation.120, 129     
 
4.2.3. Energy method required 
Nanoemulsions can sometimes require a high-energy method of preparation 
whereas microemulsions can utilize low-energy preparation methods.124 In high energy 
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methods, nanoemulsions are created when mechanical energy can overcome the surface 
tension energy barrier.139 High-pressure homogenization or colloidal mill devices are 
some of the commercial unit operations utilizing high mechanical energy.139  
Self-assembly is utilized for microemulsion formation. When microemulsions are 
created, the interfacial area is increased as the droplet size decreases.124 This causes the 
overall entropy to increase which causes the system to be thermodynamically favorable 
by having negative free energy.124 Microemulsification can be increased when heat 
and/or mechanical agitation is applied to the system.124 Non-ionic surfactants are 
commonly used to induce phase inversion to form microemulsions.124 Surfactants cause a 
lowering of surface tension due to adsorbing strongly at the interface of materials.131 By 
lowering the interfacial tension, surfactants also lower the Laplace pressure inside a 
droplet.131  
Nanoemulsions and microemulsions can also be created using the Phase Inversion 
Temperature (PIT) method. PIT is a low-energy method where the composition of an 
emulsion can be kept constant while the temperature is increased and then rapidly 
decreased to create the spontaneous formation of droplets that are smaller in size than 
before.122, 140  The PIT is the temperature where the affinity of the surfactant for the water 
and oil phases used is balanced, and rapid cooling once the PIT is reached results in the 





Emulsions are not thermodynamically stable, and interfacial tension between oil 
and water phases needs to be reduced to have a thermodynamically stable system.120 
Surfactants are molecules that can reduce the interfacial tension between water and oil 
phases.141 When surfactants are not used, the volume fraction of each phase heavily 
influences the type of emulsion that is formed. When a surfactant is present, the 
surfactant used will determine the type of emulsion formed, regardless of the volume 
fraction of the phases.123  
 
4.3.1.1. Hydrophile-lipophile balance (HLB) 
The HLB is a measure of the hydrophobic and hydrophilic parts of a molecule and 
can be used to classify surfactants.122-123 The numeric HLB value is based on the weight 
addition of the surfactant compared to the hydrophile-lipophile property of the 
surfactant.142 An HLB value ranges from 1-20 and will indicate whether a surfactant is 
more soluble in water or oil.123 Surfactants with an HLB value above 8 are mainly 
hydrophilic and can form O/W emulsions, while HLB values below 6 are hydrophobic 
and can form W/O emulsions.124, 136 An HLB near 7 has relatively equal solubility in both 
oil and water phases, causing the solubility to not be very high.122  
 
4.3.1.2. Surfactant stabilized emulsions  
Surfactants are amphiphilic molecules that have a polar, hydrophilic head group 
with a non-polar, hydrophobic tail.123-124 Interfacial tension in an emulsion system is 
lowered by surfactant addition to a solution.135 When surfactants are added into oil and 
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water mixtures, the surfactants will self-assemble at the oil-water interface.130 To ensure a 
system can have a stable and long shelf life, surfactants are considered necessary.130  
Surfactant types can also vary and be classified as either non-ionic, anionic, 
cationic, or Zwitterionic depending on the head group charge.123-124 No charge on 
surfactant head groups yield non-ionic surfactants, negative charges yield anionic 
surfactants, positive charges provide cationic surfactants, and Zwitterionic surfactants 
have head groups with both charges present.123 Phospholipids, such as lecithin, are 
Zwitterionic and are highly utilized in emulsion creation.124 The tail part of surfactants 
are made up of single or multiple non-polar hydrocarbon chain.123 Single chain 
surfactants are highly hydrophilic so a cosurfactant or electrolyte is required, but double 
chain surfactants are not mandatory for microemulsion formation.135 
As mentioned, cosurfactants can also be added into emulsion systems. 
Cosurfactants are often used to create microemulsions due to their ability to lower 
interfacial tension.124, 136 The decrease in interfacial tension is due to the cosurfactant 
being able to reduce the dielectric constant of the water phase.136 Medium- to short-chain 
alcohols can act as cosurfactants by reducing interfacial tension that causes a barrier 
between the oil and water phases, leading to solubility being higher.124 
 
4.3.1.3. Non-ionic surfactants 
The food industry utilizes non-ionic surfactants due their biodegradability and the 
wide range of HLB values available.123 Common non-ionic surfactants include sugar 
esters that have head groups derived from items such as, but not limited to, glucose, 
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sucrose, and raffinose and tail groups originating from palmitic, oleic, or linoleic acid.123-
124, 143 
 
4.3.1.4. Sorbitan esters and polysorbates  
Sorbitan esters of fatty acids are non-ionic surfactants that are also known as 
Span(s)®.144 Spans are waxy solids or viscous liquids that are products of a reaction 
between sorbitol and a fatty acid.144-145 Sorbitan esters can be modified into 
polyoxyethylene sorbitan esters or polysorbates. To produce polyoxyethylene sorbitan 
esters, sorbitan esters are reacted with ethylene oxide and a small amount of a catalyst, 
such as potassium hydroxide.146  
 Polysorbates, or Tweens, are non-ionic, hydrophilic surfactants that have a high 
HLB value.146 Tween® is a steric stabilizer due to the large hydrated polyoxyethylene 
chains repelling each other.146 The most common Tween types include Tween 20, or 
polyoxyethylene (20) sorbitan monolaurate, and Tween 80, or polyoxyethylene (20) 
sorbitan monooleate.146 Both Tweens contain 20 oxyethylene units, but the fatty acid 
associated with each polyoxyethylene sorbitan portion of the molecule differs.146 Tween 
20 is derived using lauric acid while the synthesis of Tween 80 utilizes oleic acid.146  
 
4.3.2. Disruptions to emulsion stability 
Due to the small droplet size of microemulsions, Brownian motion is the main 
mechanism describing droplet dynamics.135 When it comes to gravitational force, 
emulsions are highly affected.129 Due to the density difference between continuous and 
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dispersed phases in thermodynamically unstable emulsion systems, droplets can move 
due to gravitational influence.147 While nanoemulsions are more resistant to gravitational 
separations than emulsions, flocculation, Ostwald ripening, and coalescence can still 
occur.129  
There are multiple mechanisms that can cause emulsion stability to be disturbed, 
such as coalescence, Ostwald ripening, and gravitational separation (Figure 1.1). 
Flocculation occurs when droplets adhere to each other and form flocculates or 
aggregates of droplets.137, 148 Coalescence can cause stability issues if the surfactant used 
does not provide a strong repulsion at the droplet interface.130 When two droplets come 
into close contact, the droplets can collide and slightly deform.123 The increased surface 
area between the droplets upon contact can disrupt the interfacial tension present on the 
droplet surface which will disrupt packing of surfactants in the interfacial film.137, 149 
With disrupted interfacial packing, droplet can fuse and a large droplet will form 
containing the contents of both previously small droplets.137, 149  
If the dispersed phase has even a slight solubility in the continuous phase, 
Ostwald ripening can occur.131, 150 Smaller droplets present in the system have higher 
Laplace pressure than large droplets.150 Over time, molecules from the small droplets will 
diffuse out of the small droplet and diffuse into the large droplet that has a lower Laplace 
pressure.150 This will cause an increase in droplet size, causing instability in the 
emulsion.150  If surfactant concentration decreases, then a system will undergo Ostwald 
ripening to decrease the interfacial energy.151 The difference between Ostwald ripening 
and coalescence is that Ostwald ripening is a diffusion-driven mass transport whereas 
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coalescence is a kinetic-driven process that relies on the droplets coming into contact.131, 
137 
 
4.4. Nano- and microemulsions of essential oils and inhibition of biofilms 
Having a smaller droplet size can enable antimicrobial compounds, such as 
essential oils (EOs), to penetrate through bacterial cell walls more efficiently due to the 
small droplet size and large surface area increasing antimicrobial activity.152 Al-Adham et 
al. created a physically stable microemulsion containing 64 ppm sodium pyrithione, an 
antimicrobial derived from aspergillic acid, that was able to reduce P. aeruginosa present 
in biofilms by up to 3 log10 CFU/ml.
153 When filter plugs used for biofilm growth were 
exposed to microemulsions prior to bacterial inoculation, P. aeruginosa biofilm 
formation was 1.0 log10 CFU/ml lower than the exposure of the saline control.
153 Once 
the microemulsion was added to the biofilm-growth system, P. aeruginosa growth was 
hindered within the biofilm and viability of bacteria within the biofilm structure was 
decreased compared to the saline control.153 A nanoemulsion containing 25,000 ppm 
cinnamon oil (CO) was able to decrease S. aureus biofilms formed on stainless steel 
surfaces by 1.0 log10 CFU/cm
2 after a 15 min exposure.154  The CO nanoemulsion was 
also able to reduce S. aureus from biofilms by more than 1.0 log10 CFU/cm
2 when 
biofilms were formed in nutrient-rich microbiological media.154 A curcumin (4,000 ppm) 
and geraniol oil (20,000 ppm) microemulsion had greater biofilm inhibition of P. 
aeruginosa on plastic surfaces compared to emulsions containing 4,000 ppm curcumin by 




5. Essential oils 
Recently, emulsion antimicrobial delivery systems have been growing in 
interest.156 Emulsion systems can be easily modified to deliver a wide variety of 
antimicrobial agents.16, 156 Encapsulation has the potential to increase the antimicrobial 
activity of a compound by increasing the surface area of the particle or droplet, which in 
turn increases the bioavailability.120, 157-158 The utilization of EOs as an antimicrobial 
agent has also increased due to the increasing consumer demand for natural products.159 
EOs and their constituents can have high antimicrobial activity and have been 
encapsulated in a variety of emulsion systems.152, 160-165  
EOs are secondary metabolites in plants that assist with plant-plant 
communication, defense, and pollination and are found in the flower, bud, seeds, bark, 
fruits, leaves, and roots of a plant.166-167 EOs have been widely applied in cosmetic 
products, such as skim creams, perfumes, and soaps, and have been used for spices and 
seasonings in food.168 Recently, EOs are gaining interest as antimicrobials due to their 
antimicrobial, antifungal, antiviral, and insecticidal activity.166, 169 Additionally, many 
EOs and their constituents have been approved generally-recognized-as-safe (GRAS) 
status in the US.170  
 
5.1. An overview of EOs  
It has been observed that date of extraction, plant origin, state of the vegetable, 
growing season, and storage can contribute to differing compounds in EOs.171  EOs can 
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be obtained by physically extracting the oils from a plant through various pressing, 
distillation, and solvent extraction methods.172-174  There is discrepancy on which type of 
method to use since methods can affect the loss of volatile compounds, be too time 
intensive, be inefficient, and degrade the EO constituents in the extraction process.172, 175 
This may explain why chemical compositions for EOs vary greatly depending on 
extraction type and plant origin. Solvent extraction and steam distillation methods are the 
most common methods used for EO extraction, with cold press methods used for citrus 
EOs.172-173, 176  
Primarily, there are two circumstances that dictate whether a plant will be EO-
producing: volatiles blended in a unique manner, e.g. scented flowers, and the storage of 
volatiles from secretions.172 If the volatiles are stored from secretions, there are special 
structures, such as idioblasts or glandular trichomes, which contain the volatiles.177-178 
Each EO is comprised of a multitude of compounds in variable concentrations.166, 169 The 
primary compounds of EOs typically come from three pathways: the methyl-erythritol-
pathway giving way to mono- and diterpenes, the mevalonate pathway giving way to 
sesquiterpenes, and the shikimic acid pathway giving way to phenylpropenes.172  
 
5.1.1. Mono- and sesquiterpenes 
 Monoterpenes and sesquiterpenes both have a five carbon (C5) base unit called an 
isoprene.168-169 Due to the isoprene unit, monoterpenes have a basic C10H16 molecular 
formula while sesquiterpenes have a C15H24 molecular formula.
179 Both can be 
categorized as acyclic, monocyclic, bicyclic, and tricyclic.179 Monoterpene structures are 
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usually derived from the isoprene carbon skeleton after isomerization rearrangement or 
oxygenation causes conversion to alcohols, aldehydes, ketones, or esters, and 
sesquiterpenes are generally cyclic structures in nature.179 Monoterpenes usually 
constitute ~90% of EOs and include p-cymene, limonene, linalool, thymol, and 
carvacrol.169 A multitude of EO constituents can be in one plant, such as seen with 
oranges containing both mono- and sesquiterpenes.169, 176  
 
5.1.2. Phenylpropenes 
 Phenylpropanoids refers to any compound containing a three carbon (C3) chain 
attached to a six carbon (C6) aromatic benzene ring.
179-180 Most phenylpropanoids are 
derived from cinnamic or p-coumaric acids, which are synthesized from L-
phenylalanine.180 Phenylpropanoid metabolism provides a wide array of secondary 
metabolites that are utilized by several other metabolic pathways.180-181 Plant resistance 
towards pests can also be mediated by plant phenylpropanoid production.182 
Cinnamaldehyde from cinnamon bark and leaf oil and eugenol from cloves are common 
phenylpropanoids.183-184  
 
5.2. Mechanism of action against bacteria 
Bacterial membranes have three primary functions: to serve as a barrier from 
external forces, to act as an energy transductor, and to serve as a matrix for 
transmembrane proteins.167 Gram-negative bacteria are generally more resistant to EOs 
compared to Gram-positive bacteria due to the differences in cell wall structure (Figure 
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1.2).185 Gram-negative cell walls have a thinner peptidoglycan layer than those of Gram-
positive bacteria.16, 186 The Gram-negative peptidoglycan layer is surrounded by an outer 
membrane which are linked by Braun’s lipoprotein.186 The outer membrane is made up of 
a phospholipids bilayer that is linked to an inner membrane by lipopolysaccharides 
(LPS).186 LPS contains a polysaccharide, known as lipid A, and an O-side chain.186 
Hydrophilic transmembrane channels within the outer membrane limit passage of solutes 
into the cell and also contribute to Gram-negative bacteria being more resistant to 
hydrophobic EOs and drug treatments.186 Though passage of hydrophobic compounds are 
limited, hydrophobic molecules can still slowly travel through porins present in the cell 
membrane.186  
Antimicrobial activity of EOs is driven largely by the breakdown of chemical 
components in the EO.169, 187 Generally, antimicrobial activity of the constituents of EO 
in decreasing order are phenols > aldehydes >  alcohols > esters > hydrocarbons.188 The 
hydroxyl groups in phenolic compounds plays an important role as the hydroxyl group 
increases the solubility of the phenolics in lipids when interacting with the fatty acids 
present on the microbial cell membrane.189-191 The positioning of the hydroxyl group is 
also of importance as different placement can affect antimicrobial activity against Gram-
positive and Gram-negative bacteria.189 Stereochemistry is also highly influential in 
determining effectiveness of the EO; α- and cis-isomers tend to be inactive compared to 
β- and trans-isomers, respectively, and the unsaturation of cyclohexane rings enhances 
antibacterial properties.189 Regarding terpenoids, antibacterial effectiveness was 
increased when alkylation had occurred or if a carbonyl group was present.189 
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  It is difficult to determine the antimicrobial activity of EOs as the constituents 
can affect singular or multiple items that can result in cell death. EOs have been shown to 
degrade microbial cell walls, damage cytoplasmic membranes, disrupt the electron 
transport chain, and increase cell permeability which ultimately leads to the leakage of 
cell contents.167, 191-195 Phenolic compounds can insert into the phospholipid layer in cell 
walls and bind to proteins, causing a disruption in normal cell function.166, 191  When 
Bacillus cereus was exposed to 2 micromolar (µM) carvacrol, there was no increase in 
extracellular ATP while intracellular ATP loss was associated with a decrease in 
membrane potential.193 When using a combination of orange oil and bergamot, cell 
permeability was increased while a decrease in intracellular pH and membrane potential 
occurred.195 In both E. coli and Staphylococcus aureus, cinnamon EO treatment led to an 
efflux of electrolytes and decreased metabolic activity.196 A series of simultaneous and/or 
subsequent events caused by the introduction of EOs and/or their constituents is believed 
to be the mechanism of action rather than a singular target. For both Gram-negative and 
Gram-positive bacteria, it is understood that cell death occurs when the structural 
integrity of the cell membrane is compromised and leads to membrane permeability 
causing cell death.166, 191, 197  
Studies trying to identify an antimicrobial mechanism of action primarily 
investigate EO constituents, but there are emerging that argue that the minor constituents 
found in whole EO also contribute to the overall antimicrobial activity.166-167, 196-198 EOs 
can exhibit synergistic effects when combined with common antibacterial agents as well 
as other EOs.199-205 Some combinations of EO constituents have been shown to be more 
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effective at producing antibacterial results.199-205 In a study evaluating the effects of 32 
EOs on five different bacteria, EOs combined with a cinnamon EO displayed an additive 
antimicrobial effect against E. coli, L. monocytogenes, S. aureus, S. Typhimurium, and P. 
aeruginosa.203 When applied to lettuce surfaces, combinations of trans-cinnamaldehyde, 
a phenylpropene aldehyde from cinnamon EO, and eugenol, an allylbenzene from clove 
EO, had enhanced antimicrobial efficacy against E. coli O157:H7.205-206  
   
5.3. Cinnamon oil  
Cinnamomum zeylanicum contains a myriad of constituents.207 Cinnamaldehyde 
has been shown to be the primary EO constituent making up anywhere from 58-71% of 
the formulation of CO.161, 208-209 Depending on the extraction method, other CO 
components consist of carboxylic acid, linalool, cinnamic alcohol, and eugenol among 
other compounds.207-209  
 
5.3.1. Mechanism of action 
C. zeylanicum EO seems to be able to weaken and alter the membrane of cells and 
promote intracellular compound leakage.209 This was observed when E. coli cell walls 
appear to have collapsed after exposure to cinnamon oil (CO).209 The observed cell shape 
seem to further the idea that membrane lysis, integrity, and permeability are all acted on 
by the EO.196, 210  A separate study also reported that the lipid composition of cell 
membranes of E. coli O157:H7, S. aureus, S. Typhimurium, P. fluorescens, and B. 
thermosphacta was altered when treated with thymol, carvacrol, limonene, eugenol, or 
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cinnamaldehyde.211 A decrease in unsaturated fatty acids among all treated cells were 
evident after the EO constituent exposure.211  
 
5.3.2. Antimicrobial effectiveness against Salmonella sp. in food 
Cinnamon oil has proven effective at reducing cell counts of various Salmonella 
species in food.212-215 On organic romaine lettuce and iceberg lettuce, a 0.5% CO wash 
was compared to treatment with phosphate buffered saline and S. Newport was not 
present until after 3 days at refrigeration (4°C) and temperature abused (8°C) storage 
conditions.212 In hummus, 0.5% CO levels were able to hinder the growth of a 
Salmonella cocktail containing S. Typhimurium, S. Heidelberg, S. Kentucky, and S. 
Copenhagen for 7 days at refrigeration (4°C) and temperature abused (10°C) storage.213 
Cinnamon bark and leaf oils were also effective at reducing S. Typhimurium levels to be 
below 2.0 log10 CFU/g on fresh celery after 7 days of storage at refrigeration (4°C) 
temperature.214  
 
5.4. Orange oil (OO) 
 Citrus EOs contain a high amount of terpene hydrocarbons, which are unstable 
when exposed to heat or light.216-217 The primary constituent of OO is limonene and can 
be found at levels as high as 98%.176, 218-219 Other compounds found to make up OO are 





5.4.1. Mechanism of action and antimicrobial effectiveness against Salmonella spp. 
OO has been widely used for antifungal treatments and foodborne pathogen 
literature is limited.217, 220 The high oxygenated compound make-up of OO makes it have 
a lower inhibition level against foodborne pathogens compared to other EOs.217-218 In S. 
aureus, cold-pressed Valencia OO inhibiting cell wall synthesis when treated when 
treated with 0.1% OO for 15 minutes with cell lysis occurring within 60 min of OO 
exposure.221 OO was shown to not inhibit S. Enteritidis when in a lone-EO system.218 
Individual OO constituents had inhibition activity across 11 different Salmonella 
serotypes via disc diffusion assay.222  
 OO has also displayed synergistic antimicrobial effects when combined with 
thyme oil.223-224 Higher inhibition was seem with a thyme-OO combination against S. 
Heidelberg, S. Montevideo, S. Enteritidis than when both EOs were used separately.223 S. 
Enteritidis on inoculated broiler breast fillets and whole wings had a salt-phosphate 
marinade solution with 0.5% thyme-OO treatment, and S. Enteritidis levels were reduced 
more than 2.0 log10 CFU/ml on both the breast fillets and wings.
224  
 
6. Overview of dissertation research 
With the increased incidence of infection from S. Enteritidis and over 50% of 
CDC-reported Salmonella cases being from contaminated eggs, S. Enteritidis H4267, 
sourced from an egg outbreak, will be used for experimental examination.225-226 Despite 
the growing interest in antimicrobial delivery systems for biofilms and the increased 
incidence of infection from S. Enteritidis, an antimicrobial delivery system targeting 
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biofilms composed of S. Enteritidis H4267 has not been investigated.10, 227 As S. 
Enteritidis is the leading Salmonella serovar for human laboratory-confirmed cases, this 
research can provide knowledge on biofilm-forming characteristics of S. Enteritidis 
H4267 to assist in future antimicrobial delivery system development. The increased 
bioavailability and thermodynamic stability of microemulsions is an attractive option for 
the development of an antimicrobial delivery system.120, 129 The utilization of EOs as an 
antimicrobial will also assist with reducing the possibility of antimicrobial resistance to a 
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Figure 1.1. Representation of coalescence, Ostwald ripening, and flocculation. Oil droplets demonstrating a) coalescence, b) 
Ostwald ripening, and c) flocculation. Coalescence occurs when droplets get close together to have a hole formation form in the 
interfacial film which leads to the formation of one larger droplet. Ostwald ripening occurs when molecules in smaller droplets of 
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Chapter 3. Microemulsions containing cinnamon and orange oil: 






 Essential oils (EOs) are natural antimicrobials that can be used to develop 
intervention strategies to inhibit pathogens, but EOs are lipophilic. Colloidal systems, 
such as microemulsions, are needed for food industry applications. This study 
investigated the antimicrobial activity of cinnamon oil (CO, Cinnamomum zeylanicum) 
and orange oil (OO, Citrus sinensis) against Salmonella Enteritidis H4267, when used 
either in combination or in a microemulsion system. Disc diffusion assays indicated that 
CO had a greater antimicrobial effect on S. Enteritidis H4267 when used in combination 
with OO than when individually (p<0.001). Analyses of the minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) indicated that CO 
and OO were optimum in a 9:1 volume ratio (MIC and MBC: 750: 750 ppm). Physical 
analyses determined that, on mass basis, 0% and 2% sunflower lecithin (SL), 20% Tween 
20, 1% and 5% CO-OO (9:1) formulations were transparent, thermodynamically stable, 
and Newtonian fluids. These formulations were therefore determined to be 
microemulsions. Only formulations of 0% SL, 1% CO-OO (9:1) and 0% and 2% SL, 5% 
CO-OO (9:1) exhibited bactericidal activity against S. Enteritidis H4267. This study 
shows that OO enhances the bactericidal activity of CO when in an oil or microemulsion 
system, and co-encapsulated oils in microemulsions could be effective as antimicrobial 





An estimated 48 million cases of foodborne illnesses occur annually in the United 
States, but only 9.4 million foodborne illness-related cases have an identified pathogen 
source.1-2 Reducing these case numbers is not only of public health concern, but also of 
economic interest as it was estimated in 2015 that the economic burden of foodborne 
illnesses was over $15.5 billion.3 Of the top five causes of foodborne illnesses, 
Salmonella is the leading bacterial culprit.4-5 Among the human Salmonella isolates 
reported in the US, 99% belong to S. enterica, with the top two S. enterica isolates 
serotyped from laboratory-confirmed cases being S. Enteritidis and S. Typhimurium.6 
Between 2007 and 2015, the incidence of infection from S. Enteritidis increased by 37% 
while S. Typhimurium incidence of infection decreased by 66%.6, 7  
Antimicrobial delivery systems are of interest to combat foodborne pathogens in 
the food industry while also avoiding bacterial resistance to disinfectants.8 Plant-derived 
essential oils (EOs) are an attractive option for antimicrobial systems since EOs do not 
contribute to drug resistance due to the current mechanism of action focusing on the 
disruption of bacterial membranes.9-12 EOs are extracted from the leaves, bark, and/or 
stems of herbs and spices, are highly aromatic, and display a broad range of antioxidant, 
antiviral, and antimicrobial properties.13-14 EOs are composed of hundreds of chemical 
compounds, such as terpenes, terpenoids, and phenylpropenes.15 The hydrophobicity of 
EOs allows for penetration through bacterial cell membranes to disrupt cellular metabolic 
processes and membrane transport systems.10-11 These disruptions ultimately lead to the 
breakdown of the cell membrane integrity and cause increased membrane permeability.10 
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The hydrophobicity of EOs also requires colloidal systems, such as emulsions, for 
utilization. 
 Colloidal systems with nanoscale oil droplets have unique features uncommon in 
conventional emulsions.16-17 Nanoemulsions have a droplet diameter between 20 and 200 
nm, and microemulsions have an oil droplet dimension between 4 and 100 nm.16 While 
nanoemulsions and microemulsions have overlapping dimensions, nanoemulsions are 
metastable systems that can be clear or turbid in appearance, and microemulsions have 
the added benefit of being transparent and thermodynamically stable oil-water-surfactant 
mixtures.16, 18 Nanoemulsions of EOs are susceptible to Ostwald ripening as the water-
solubility of an EO compound contained within a droplet increases as the size of the oil 
droplet decreases, which contrasts with stable oil droplets in microemulsions.16, 19-20 Due 
to the small droplet size and large surface area, microemulsions have the ability to enable 
EO compounds to penetrate through bacterial cell walls more efficiently, which can 
increase the antimicrobial activity.21 Additionally, microemulsions are relatively easy to 
prepare in comparison to nanoemulsions that may require high-energy methods for 
forming nanoscale droplets.22  
 While there are several benefits of microemulsions, microemulsions are formed 
only at a particular set of conditions, such as environmental conditions and composition, 
and may convert to a different colloidal system when the conditions are changed.16-17 
Microemulsions also require a high level of surfactants.16 Despite these drawbacks, the 
oil body of microemulsions can be used to dissolve lipophilic compounds, which could 
be an approach to enhance antimicrobial activity. 23-24 
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 When combined with other organic compounds, the antimicrobial activity of the 
individual EOs may be enhanced to provide greater antimicrobial ability at reduced 
levels.25 Cinnamon (Cinnamomum zeylanicum) oil (CO) has been extensively researched 
as an antimicrobial against a variety of foodborne pathogens, and cinnamon bark oil has 
displayed enhanced antimicrobial activity against S. Enteritidis in the presence of other 
EOs.26-29 Citrus oils have exhibited inhibitory activity against a variety of S. enterica and 
have displayed antimicrobial activity enhancement of other EOs when used in 
combination against Salmonella sp.30-31 Cinnamaldehyde in CO, a phenylpropene 
aldehyde, and citrus oils containing monoterpenoid alcohols, aldehydes, and 
monoterpenes, such as linalool, citral, and limonene, have antimicrobial and/or antifungal 
activity when applied individually.15, 25, 32-33 The possible synergy in antimicrobial 
activity of CO and citrus oil has not been studied.  
 
2. Hypothesis 
CO and OO are hypothesized to have inhibitory activity against planktonic S. 
Enteritidis H4267 when used in combination due to OOs ability to enhance the 
antimicrobial activity of other EOs against Salmonella sp. and COs bactericidal activity 
against S. Enteritidis alone and in combination with other EOs.28, 30-31 With the 
adjustment of surfactants concentrations, a microemulsion containing CO and OO may be 
formed. Microemulsions with co-encapsulated oils have been created and characterized 
previously.23-24 Microemulsions containing CO and OO are hypothesized to have a lower 
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antimicrobial ability compared to the lone-EOs due to the inclusion of surfactants and/or 
emulsifiers.34-39  
This hypothesis was tested in three phases. Phase 1 determined the antimicrobial 
ability of CO and OO against S. Enteritidis H4267 while Phase 2 investigated the 
development and characterization of microemulsions containing co-encapsulated CO and 
OO. After microemulsions were developed, Phase 3 determined the antimicrobial activity 




CO was a product of Sigma-Aldrich Corp. (St. Louis, MO). OO was purchased 
from Now Essential Oil, Co. (Bloomingdale, IL). Tryptic soy broth (TSB) and tryptic soy 
agar (TSA) medium powders were products of Remel (San Diego, CA) and were 
dissolved in 1 l of deionized water (diH2O) prior to autoclave sterilization. Tween
® 20 
was a product of Acros Organics (Morris Plains, NJ), and sunflower lecithin (SL) was 
purchased from Perimondo LLC (New York, NY). Ethanol (200 proof) utilized was a 
product of Decon Laboratories, Inc. (King of Prussia, PA). 
 
3.2. Bacterial culture  
S. Enteritidis H4267 was obtained from the Department of Food Science culture 
collection at the University of Tennessee (Knoxville, TN) and was maintained at -20ºC in 
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25% glycerol. The strain was transferred two times in TSB with 22±2 h incubation at 
37ºC prior to use.  
 
3.3. Disc diffusion assay 
Disc diffusion assay experiments were adapted from O’Bryan et al.30 S. 
Enteritidis H4267 was serially diluted to ~106 CFU/ml, and 100 µl of the diluted culture 
was spread onto TSA. Four sterile paper discs with a diameter of 6 mm (Thermo Fisher 
Scientific, Waltham, MA) were aseptically placed onto the inoculated agar surface. CO 
and OO were pipetted at various volume ratios up ranging from 1-10 µl volume per paper 
disc, followed by incubation at room temperature (21±2°C) for 30 min, inversion, and 
incubation at 37ºC for 22±2 h. The positive control was Salmonella-spread plates with 
paper discs without EOs; the negative control was uninoculated plates with paper discs 
without EOs. After incubation at 37ºC for 22±2 h, diameters of inhibition zones around 
each disc were measured using a ruler with a precision of 1 mm. Plates were completed 
in triplicate for each level of EOs (n = 4, N = 12). 
 
3.4. Minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of EOs 
A microbroth dilution method for MIC determination was utilized.40 The bacterial 
culture was diluted to ~106 CFU/ml in TSB, and 100 µl of the diluted culture was added 
to wells in a 96-well microtiter plate (Corning Inc., Corning, NY). CO and OO stock 
solutions were solubilized at 30% v/v and 20% v/v in 70% and 80% ethanol, respectively, 
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to completely dissolve EOs. The EO stock solutions were diluted in TSB to 5000 ppm, 
followed by half-dilution with TSB to an EO concentration as low as 25 ppm as working 
solutions. The ethanol levels corresponding to EO working solutions were confirmed to 
have no inhibition on S. Enteritidis H4267 at the studied conditions. A 100 µl aliquot of 
an EO working solution was added to a well. Plates were covered, and optical density 
(OD) was measured (Synergy HT Microplate Reader, BioTek Instruments, Inc., 
Winooski, VT) at 630 nm before and after incubation at 37°C for 24 h. The positive 
controls were the diluted bacterial culture, and the CO and OO stock solutions; the 
negative controls were the EO working solutions alone and sterile TSB. The MIC was 
determined to be the lowest EO level that had an OD change (ΔOD630 nm) of <0.05.
41 The 
MBC was determined by spread plating 100 µl of the mixture from negative wells and 
the bracketing wells onto TSA plates. Plates were incubated at 37°C for 22±2 h. The 
MBC was determined as the antimicrobial solution level that resulted in at least a 3-log 
reduction of viable cells.41   
 
3.5. Antimicrobial activity of CO-OO combinations  
Interactions of CO and OO used in combination were assessed using a 
checkerboard method.41 Wells were loaded with varying volumes of the EO working 
solutions, prepared as above with 25-5000 ppm CO or OO, totaling 100 µl in volume, 
and 100 µl of diluted S. Enteritidis H4267 culture (~106 CFU/ml). The MIC and MBC 
were determined as previously described. If an antimicrobial combination had an MIC, 
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the fractional inhibitory concentration (FIC) index was calculated (Equation 2.1) where 
antimicrobial A is CO and antimicrobial B is OO.42    
 
FIC =
𝑀𝐼𝐶 𝑜𝑓 𝐴 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛
𝑀𝐼𝐶 𝑜𝑓 𝐴 𝑎𝑙𝑜𝑛𝑒
+
𝑀𝐼𝐶 𝑜𝑓 𝐵 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛
𝑀𝐼𝐶 𝑜𝑓 𝐵 𝑎𝑙𝑜𝑛𝑒
 
 
Synergistic interaction would be an FIC index value of <1, while additive and 
antagonistic interaction of the antimicrobial combination would be 1 and >1, 
respectively.42  
 
3.6. Microemulsion preparation  
Microemulsion preparation followed a previous work, with modification for 
compositions.24 CO and/or OO were added to scintillation vials on mass basis at 0% to 
25% levels along with 20% Tween 20 in CO-OO volume ratios of 1:1 or 9:1. A 12% 
stock solution of SL was prepared with diH2O by stirring for 8 h at room temperature 
(21±2°C) and added to solution vials, on mass basis, at 0% to 6%. Deionized water was 
added to vials to bring the total emulsion mass to 15.0 g, and the mixture was hand-
agitated until visually homogenous, followed by heating in an 80ºC water bath for 5 min. 
After heating, vials were hand-agitated in an ice water bath (5±0.5ºC).  Formed 
emulsions were visually assessed for transparency, used as a preliminary indication of 





3.7. Physical properties of emulsions 
Droplet size. Droplet size distribution was determined using dynamic light 
scattering (Zeta Sizer S, Malvern Panalytical Ltd., Worcestershire, UK) at a 173º 
scattering angle. Emulsions were diluted 100-fold in diH2O to fit instrument sensitivity. 
Measurements were performed thrice for each sample, and emulsions were completed in 
triplicate (n = 3, N = 9).  
 
Thermal and storage stability of droplets. Emulsions were stored at refrigeration 
(5±2ºC) or freezing (-20±5ºC) temperatures for 24 h and were returned to room 
temperature (21±2ºC) for 24 h to determine droplet size distribution and the 
thermodynamic stability. Emulsions were also measured for droplet size distributions 
after storage at room temperature for 0, 30, and 60 d. The ability to restore droplet size 
distribution after temperature fluctuations and long-time storage, as determined by 
thermodynamic stability, is one way to differentiate between a nanoemulsion and a 
microemulsion.16 
 
Rheological property. Emulsion viscosity was determined using a model AR2000 
rheometer (TA Instruments, New Castle, DE) with a concentric cylinder geometry (cup 
inner diameter 30 mm, bob out diameter 28 mm). Shear rate ramps were performed from 




Zeta(ζ)-potential. ζ-potential of samples was measured using the same dynamic 
light scattering instrument as described above. Samples were diluted 100-fold in diH2O 
and were completed in triplicate (n = 3, N = 9). 
 
3.8. Antimicrobial activity of microemulsions 
After microemulsions were identified, disc diffusion assays using a 10 µl volume 
of microemulsion per disc was performed as described previously in Section 3.2. The 
positive control was Salmonella-spread plates with sterile paper discs only; the negative 
controls included uninoculated plates with paper discs only or paper discs treated with 10 
µl of Tween 20, diH2O, or SL. After incubation at 37ºC for 22±2 h, diameters of 
inhibition zones were measured (n = 4, N = 12).  
The assays for MIC and MBC determination as presented previously in Section 
3.3 were adapted for microemulsions. Microemulsions were diluted 0-, 50-, 100-, 200-, 
and 300- fold in diH2O, and 100 µl of the diluted microemulsion was added to a 
treatment well with 100 µl of culture with ~106 CFU/ml bacteria. The positive control 
was the diluted bacterial culture. The rest of experiments followed the same protocol 
previously described.   
 
3.9. Statistical analysis  
One-way analysis of variance (ANOVA) was used to identify significant 
differences among treatments (α = 0.05). Pairwise significant differences were 
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determined using Tukey’s test after conducting ANOVA. Analyses were conducted using 
SAS v9.4 (SAS Inc., Cary, NC, USA). 
 
4. Results 
4.1. Disc diffusion assay for oils 
Discs that displayed no inhibition were recorded as the size of the disc diameter (6 
mm) (Figure 2.1) (All tables and figures are located in the appendix of this chapter). 
Discs treated with neat OO did not show inhibition while those treated with neat CO and 
CO-OO combinations displayed zones of inhibition (Table 2.1). CO-OO combinations at 
all volume ratios showed statistically larger (p<0.05) inhibition zones than neat CO 
treatment. However, there was no significant difference between treatments with various 
CO-OO combinations. The CO-OO ratios of 1:1 and 9:1 were chosen for further study 
due to the 1:1 ratio being lower in cost and the 9:1 ratio having the highest CO 
concentration, which is the EO that displayed bactericidal activity.  
 
4.2. MIC, MBC, and interactions of CO and OO 
Stock solutions of CO and OO did not differ (α=0.05) in ΔOD630nm values 
compared to the S. Enteritidis H4267 positive control (data not shown). Wells treated 
with up to 2500 ppm neat OO had ΔOD630nm values >0.05 (Table 2.2). The CO-OO 
combination at 9:1 ratio displayed MICs and MBCs at 750: 500 ppm and 1,000: 250 
ppm, respectively, while the CO-OO combination at 1:1 ratio resulted in an MIC and 
MBC with CO (1,250: 750 ppm) at a level the same as that of the neat CO.  
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4.3. Physical properties of microemulsions 
Thermal and storage stability of droplet size. Only the 0 and 2% SL formulations 
displayed transparent emulsions after storage for 1 d at room temperature and were 
selected for thermal and storage stability experiments (Figure 2.2). While all emulsions 
had a slight increase in droplet size after temperature abuse, the emulsions displayed a 
transparent appearance and stayed within microemulsion droplet size range after 
temperature abuse in freezer (-20±5ºC) or refrigeration (5±2ºC) (Figure 2.3). The 0% SL, 
5% CO-OO (1:1) and 2% SL, 1% CO-OO (1:1) indicated changes in intensity peaks after 
temperature abuse.  
Concurrent to the temperature abuse studies, transparent emulsions were 
measured for droplet size at over 60 days (Figure 2.4). There was no change in droplet 
dimension after 60 d and single intensity peaks remained. The formulations of 0 and 2% 
SL with 1% CO-OO (9:1, 1:1), 0% SL with 5% CO-OO (9:1), and 2% SL, 5% CO-OO 
(9:1) were classified as microemulsions due to having droplet dimensions ranging from 
~8-14 nm over 60-day storage, remaining transparent in appearance, and returning to 
microemulsion droplet size with single intensity peaks after temperature abuse.  
Microemulsions displayed a linear correlation (R2 values >0.99) between shear 
rate and shear stress and had an intercept of zero (Figure 2.5), indicating the formulations 
are Newtonian fluids. The ζ-potential for all microemulsions was slightly below 0 mV 




4.4. Antimicrobial activity of microemulsions determined with disc diffusion assay  
 All microemulsion formulations displayed inhibition of S. Enteritidis H4267 via 
disc diffusion (Table 2.3). There was no difference (α=0.05) between the microemulsion 
formulations in relation to mean inhibition zone diameter.  
 
4.5. MIC and MBC of microemulsions  
 All microemulsions displayed inhibition against S. Enteritidis H4267 at 0-fold 
dilution only (data not shown). Since water did not demonstrate inhibition of growth via 
disc diffusion (Table 2.3), dilution with water was anticipated to promote bacterial 
growth. Once plated, only 0% SL, 1% CO-OO (9:1), and 0% and 2% SL, 5% CO-OO 
(9:1) microemulsion systems had a bactericidal effect (Table 2.4). The ability for the 2% 
SL, 5% CO-OO (9:1) microemulsion to have bactericidal activity, while the 1% (9:1) 
formulation did not, suggests that a higher level of CO is needed to overcome the 
addition of SL. The 0% SL, 1% CO-OO (1:1) microemulsion displayed the most 
bactericidal activity for the tested 1:1 microemulsion formulations, but the resulting 
colony count did not fit the MBC criteria of having a 3-log reduction.41  
 
5. Discussion 
The average inhibition zone of the neat CO treatment (11.0±1.7 mm) against S. 
Enteritidis H4267 is within the range of other studies on a variety of other S. Enteritidis 
strains (11.0±3.9 mm).28 The lack of inhibition of S. Enteritidis by OO also aligns with 
previous studies indicating that 10 µl of OO did not display inhibition against S. 
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Enteritidis via disc diffusion.28, 30 Inhibition of S. Enteritidis by OO was previously 
indicated to be above 1,000 ppm, a lower level than the 2,500 ppm in the present study 
testing on S. Enteritidis H4267.28, 30-31  The MIC and MBC of CO in this study were both 
1250 ppm. Ebani et al.28 found that CO had an MIC of 1,260 ppm on five different S. 
Enteritidis strains, and Raybaudi-Massilia et al.27 indicated CO levels above 1,000 ppm 
were needed for S. Enteritidis inhibition. Although antimicrobial combinations had MICs, 
synergistic interaction utilizing the FIC index was not able to be determined since an 
MIC for OO was not able to be determined. This suggests that OO is enhancing the 
antimicrobial activity of CO, but the synergistic interaction between CO and OO cannot 
be determined based on estimating the FIC index.42 
A characteristic of microemulsions is the thermodynamic stability.16  Droplets 
should stay within 4-100 nm in diameter, and microemulsions should remain transparent 
over time.16, 43 When removed from the optimal temperature environment, 
microemulsions can become unstable, but when returned to optimal temperature 
conditions, the emulsion should return to a microemulsion.16, 43 The 0% SL, 5% CO-OO 
(1:1) and 2% SL, 1% CO-OO (1:1) are more indicative of nanoemulsions, metastable 
formulations that break down over time and are not thermodynamically stable.17 
Nanoemulsions may have multiple or single peaks in droplet size distribution, while 
microemulsions have a single narrow peak.43 The high surfactant level present in the 
formulations can encapsulate oils but will also contribute free surfactant micelles that can 
transfer oil molecules between droplets through Ostwald ripening, which has been seen 
with other OO nanoemulsions.44-46 Ostwald ripening can occur in systems where the 
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dispersed phase has solubility in the aqueous phase.47-49 Citrus oils contain large amounts 
of hydrophilic components.15 Small water-soluble components can diffuse and become 
larger droplets due to Ostwald ripening.48 Since components in CO and OO are expected 
to have some water solubility, both Ostwald ripening and coalescence can occur in those 
systems after temperature abuse.15 The microemulsions displaying Newtonian fluid 
characteristics agree with literature of other microemulsion systems demonstrating 
Newtonian characteristics.24, 50-51  Since the majority of bacterial surfaces have a negative 
charge, the ability of microemulsions to be attracted to bacterial surfaces can be hindered 
if the negative charge is strong enough.52 
The addition of surfactants can hinder the antimicrobial ability of oils when 
encapsulated.34, 53 Although Tween 80 has displayed inhibition against a variety of 
microorganisms,35 the Tween 20 control did not inhibit S. Enteritidis H4267 at the 
volumes applied to discs. The level of Tween 20 utilized is above a critical concentration 
(4% Tween 20 total in an emulsion) that could cause S. Enteritidis H4267 cell death and 
is acting as a nutrient source and growth promoter.35, 54-57 Lecithin presence can also 
increase the growth of microorganisms by supplying fatty acids to microbial cells, which 
can trigger events that ultimately increase biomass.34 It has been reported that lecithin 
below 0.005-1.0% (w/v) improved antimicrobial properties of EOs, but lecithin above 
these concentrations showed no antimicrobial activity.58-60 The lack of antimicrobial 
activity via disc diffusion from Tween 20 and lecithin further strengthen the conclusion 
that the antimicrobial activity is being driven by the co-encapsulated CO and OO. 
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CO nanoemulsions have shown increased antimicrobial ability against both Gram 
positive and Gram negative bacteria when CO content in the lipid phase increased, but 
MICs of the emulsion system were not lower than that of neat CO.53 Heating during 
microemulsion preparation could have contributed to the conversion of cinnamaldehyde, 
a primary component in CO that has antimicrobial properties, into benzaldehyde, an 
oxidative product that has been reported to have no inhibitory effect against a variety of 
Gram positive and Gram negative organisms.53, 61-62 Room temperature storage of OO has 
shown that chemical components oxidize over time into secondary constituents, and heat 
can expedite the process.63 Tween surfactants, known to undergo hydrophobic 
interactions with EO constituents can reduce EO antimicrobial interaction with 
bacteria.36-39 Further research into determining the extent of EO degradation should be 
investigated prior to altering preparation methods utilizing low-temperature methods and 
altering surfactant concentration.   
 
6. Conclusion 
OO enhanced the antimicrobial ability of CO against S. Enteritidis H4267, both in 
simple oil combination and in microemulsion systems. Multiple microemulsions were 
formulated with CO-OO present in 9:1 and 1:1 volume ratios at up to 5% oil 
concentration. Microemulsions were thermodynamically stable for 60 d and after 
temperature abuse, were Newtonian fluids, and had a slight negative charge. Only 
microemulsions containing 9:1 CO-OO ratios had bactericidal activity against S. 
Enteritidis H4267, with 2% SL, 1% CO-OO (9:1) only having inhibitory activity. 
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Microemulsions containing co-encapsulated CO and OO could be used as an 
antimicrobial delivery system against S. Enteritidis H4267.  
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Table 2.1. Mean inhibition zone diameter of treatments of cinnamon oil (CO), 
orange oil (OO), or their different volume ratio combinations in total volume of 10 
µl against S. Enteritidis H4267.  
System tested Mean inhibition zone diameter (mm)b  
CO (10 µl) 11.0±1.7 (B) 
CO (9 µl) 10.9±1.7 (B) 
CO (8 µl) 10.5±1.2 (B) 
CO (7.5 µl) 10.6±1.3 (B) 
CO (7 µl) 11.9±1.8 (B) 
CO (6 µl) 11.7±1.8 (B) 
CO (5 µl) 11.5±1.3 (B) 
CO (2.5 µl) 11.5±1.9 (B) 
OO (1-10 µl) 6.0±0.0 (C) 
CO-OO (9:1)  18.6±2.0 (A) 
CO-OO (4:1) 18.5±1.5 (A) 
CO-OO (3:1) 18.6±1.7 (A) 
CO-OO (7:3) 18.6±1.6 (A) 
CO-OO (3:2) 18.3±0.7 (A) 
CO-OO (1:1) 18.8±0.6 (A) 
CO-OO (0.5:0.5) a 18.8±0.8 (A) 
112 
 
Table 2.1 Continued  
Negative control (uninoculated) 6.0±0.0 (C) 
Positive control (without oil) 6.0±0.0 (C) 
a The treatment was an exception with 2.5 µl of each oil. 
b Treatments with a zone diameter equivalent to the bore diameter of 6 mm indicate no 





Table 2.2. Minimum inhibitory concentration (MIC, ppm) and minimum 
bactericidal concentrations (MBC, ppm) of cinnamon oil (CO), orange oil (OO), and 
their combinations at 1:1 or 9:1 mass ratio against S. Enteritidis H4267.a  
Oil MIC MBC a 
CO 1,250 1,250 (A) 
OO >2,500 None b 
CO-OO (1:1) 1,250: 750 1,250: 750 (A) 
CO-OO (9:1) 750: 750 750: 750 (A) 
a Different letters indicate significantly different (α=0.05) means of MBC plate counts 
on tryptic soy agar. 





Table 2.3. Mean inhibition zone diameter of samples containing, on mass basis, 20% 
Tween 20, varying amounts of deionized water, 0 or 1% sunflower lecithin (SL), 1% 
or 5% oil with cinnamon oil (CO) and orange oil (OO) at a mass ratio of either 9:1 
or 1:1 against S. Enteritidis H4267, in comparison to individual components.  
System tested Mean inhibition zone diameter (mm)a  
0% SL, 1% CO-OO (1:1) 10.1±1.2 (A) 
0% SL, 1% CO-OO (9:1) 9.8±1.6 (A) 
2% SL, 1% CO-OO (9:1) 9.4±1.3 (A) 
0% SL, 5% CO-OO (9:1) 11.0±2.0 (A) 
2% SL, 5% CO-OO (9:1) 10.5±1.5 (A) 
Deionized water 6.0±0.0 (B) 
Tween 20 6.0±0.0 (B) 
12% SL 6.0±0.0 (B) 
Positive control (no treatment) 6.0±0.0 (B) 
a Treatments with a zone diameter equivalent to the bore diameter of 6 mm indicate no 
inhibition. Different letters indicate significantly different (α=0.05) means of inhibition 





Table 2.4. Minimum inhibitory concentrations (MIC, ppm) and minimum 
bactericidal concentrations (MBC, ppm) of samples containing, on mass basis, 20% 
Tween 20, varying amounts of deionized water, 0 or 1% sunflower lecithin (SL), 1% 
or 5% oil with cinnamon oil (CO) and orange oil (OO) at a mass ratio of either 9:1 
or 1:1 against S. Enteritidis H4267.a  
System tested MIC MBC a 
0% SL, 1% CO-OO (1:1) 2,500: 2,500 None b (B) 
0% SL, 1% CO-OO (9:1) 4,500: 500 4,500: 500 (A) 
2% SL, 1% CO-OO (9:1) 4,500: 500 None (B) 
0% SL, 5% CO-OO (9:1) 22,500: 2,500 22,500: 2,500 (A) 
2% SL, 5% CO-OO (9:1) 22,500: 2,500 22,500: 2,500 (A) 
a Different letters indicate significantly different (α=0.05) means of MBC plate counts 
on tryptic soy agar.  







Figure 2.1. Disc diffusion assay diameter of inhibition zones of CO and/or OO against S. Enteritidis H4267. CO and/or OO 
in neat form or combination in volume ratios against S. Enteritidis H4267 on filter discs on tryptic soy agar plates. Discs without 
inhibition were recorded as the size of the disc (6 mm). Different letters indicate significantly different (α=0.05) means via 
Tukey’s Studentized Range (n=4, N=12). 
A A A A A A
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Figure 2.2. Emulsion transparency after creation. Visual clarity of emulsions containing 0 to 6% (w/w) sunflower lecithin 
(SL), 20% (w/w) Tween 20, deionized water, and 1-25% (w/w) CO and OO in either a 1:1 (left) or 9:1 (right) volume ratio. 
1% 5% 10% 15% 20% 25% 1% 5% 10% 15% 20% 25% 
0% (w/w) SL 0% (w/w) SL 
4% (w/w) SL 4% (w/w) SL 
2% (w/w) SL 2% (w/w) SL 





Figure 2.3. Droplet size distribution of emulsion formulations pre- and post-
temperature abuse. Droplet size distributions of emulsion formulations held at room 
temperature (21±2°C) and after being held in a freezer (-20±5°C) or refrigerator (5±2ºC) 
for 24 h and warming to room temperature for 24 h. Samples contained, on mass basis, 
0% or 2% sunflower lecithin (SL), 20% (w/w) Tween 20, 1% or 5% (w/w) cinnamon oil 






























Figure 2.3 Continued 
 









































0% SL, 1% CO-OO (9:1) 




Figure 2.3 Continued 
 









































0% SL, 5% CO-OO (9:1) 




Figure 2.3 Continued 
 









































2% SL, 1% CO-OO (9:1) 





Figure 2.4. Droplet size distribution of emulsion formulations held over 60 d. Droplet 
size distribution of emulsions held for 60 days at room temperature (21±2°C). Samples 
contained, on mass basis, 0% or 2% sunflower lecithin (SL), 20% (w/w) Tween 20, 1% 
or 5% (w/w) cinnamon oil (CO) and orange oil (OO) in either 1:1 or 9:1 volume ratios, 






























Figure 2.4 Continued 
 







































0% SL, 1% CO-OO (9:1) 




Figure 2.4 Continued 
 







































0% SL, 5% CO-OO (9:1) 




Figure 2.4 Continued 
 







































2% SL, 1% CO-OO (9:1) 




Figure 2.5. Shear rate ramps of microemulsions. Shear rate ramps at 25°C of microemulsions containing, on mass basis, 20% 
Tween 20, varying amounts of deionized water, 0 or 2% sunflower lecithin (SL), 1% or 5% oil with cinnamon oil (CO) and 





























Average Shear Rate (1/s)
0% SL, 1% CO:OO (1:1)
0% SL, 1% CO:OO (9:1)
0% SL, 5% CO:OO (9:1)
2% SL, 1% CO:OO (9:1)




Figure 2.6. Zeta-potential of microemulsions. Zeta-potential of microemulsions containing, on mass basis, 20% Tween 20, 
varying amounts of deionized water, 0 or 2% sunflower lecithin (SL), 1% or 5% oil with cinnamon oil (CO) and orange oil (OO) 



























0% SL, 1% CO:OO (1:1)
0% SL, 1% CO:OO (9:1)
0% SL, 5% CO:OO (9:1)
2% SL, 1% CO:OO (9:1)
2% SL, 5% CO:OO (9:1)
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Salmonella is the leading bacterial culprit of foodborne illness in the US and S. 
Enteritidis, the leading Salmonella serovar associated with foodborne illness, has been 
shown to produce biofilms on stainless steel surfaces.1-4 Determining biofilm-forming 
capabilities is important as Salmonella spp. can have differing capabilities.5 Biofilm-
forming abilities were determined with red, dry, and rough morphotypes present Congo 
Red Agar (CRA), fluorescence of colonies on Luria Broth agar with 0.02% (w/v) 
calcofluor (LBAc) plates and via microtiter assay. S. Enteritidis H4267 displayed curli- 
and cellulose producing capabilities on CRA and LBAc while also displaying formed 
biofilms on microtiter well walls after incubation at 37°C for 24 h. Biofilms were then 
formed on stainless steel discs, and sonication was evaluated for removal efficacy. 
Stainless steel discs that were rinsed and sonicated in 0.1% (w/v) peptone water (PW) for 
30 sec (25% power, 5 kHz) had the greatest S. Enteritidis H4267 recovery while not 
causing high cell death. This research demonstrates that S. Enteritidis H4267 can form 
biofilms on microtiter well walls and stainless steel surfaces, which has not been shown 
previously. Biofilms can also be effectively removed from stainless steel discs with rinse 
in 0.1% PW followed by 30 sec sonication at 25% power for enumeration purposes.  
 
1. Introduction 
Equipment and devices used in the food industry can vary in use and material 
type.6 Glass and plastic are commonly used in the food industry, but metals, used more 
often, are the most important material for food processing equipment.5, 7-8 The large 
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variety of equipment surfaces, material types, high water usage, and human personnel 
present in a food processing facility all contribute to bacterial growth being present in a 
food facility.6, 9 If cleaning and hygienic practices are not implemented consistently, 
microorganisms can thrive in a food facility and biofilms can form.6, 10  
A biofilm is a community of microorganisms that are attached to a surface and 
encased in an exterior matrix.9, 11 Biofilms can form on a variety of surfaces and become 
difficult to remove since biofilm communities have greater antimicrobial resistance.12-14 
Biofilms present in food processing environments can serve as a persistent pathogen 
source as biofilm pieces can detach, allowing for microorganisms to travel throughout a 
facility.15-17 Products, materials, and contact and non-contact surfaces within a facility 
can become contaminated, which can lead to large scale effects, such as food recalls and 
plant closures.10, 15-17 
Salmonella is the leading bacterial culprit of foodborne illness in the US with an 
estimated one million cases of foodborne illness attributed to Salmonella infection.1-2, 18 
S. Enteritidis is the leading Salmonella serovar associated with foodborne illness and has 
been shown to produce biofilms on stainless steel, glass, and plastic surfaces.3-4, 19-22 The 
majority of Salmonella biofilm extracellular matrices are composed of curli and 
cellulose.23 Both curli and cellulose are able to provide structure and promote cell 
adhesion to surfaces to form biofilms.23 Curli are thin, aggregative, amyloid fimbriae that 
are important for both surface adhesion and host infection.24-25 Cellulose is a 
polysaccharide that has been shown to be a major contributor towards Salmonella biofilm 
formation and antimicrobial resistance.23, 26-27 Each Salmonella serovar can have differing 
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biofilm-forming capabilities, and determining the curli- and cellulose-forming abilities is 
needed when developing a biofilm.5, 28  
Congo Red agar (CRA) and Luria Broth agar with 0.02% (w/v) calcofluor (LBAc) 
have been used to determine biofilm forming abilities of bacteria.5, 23, 28 Biofilms can also 
be formed in a microtiter well and be indirectly quantified by solubilizing crystal violet 
(CV)-stained cells in 30% (v/v) acetic acid.29-30 CV will bind to proteins present in 
microbial cell walls and can indicate bacterial presence while solubilization of the CV in 
30% acetic acid can quantify the extent of microbial abundance.29-31  
Various methods exist for biofilm removal from a surface.32-33 Swabbing, 
sonication, or scraping of material surfaces as well as rinsing prior to enumeration are all 
methods that have been utilized.32-33 Sonication has been described as being superior to 
both swabbing and scraping for biofilm removal, but the length of sonication must be 
limited as prolonged exposure can cause cell death, which can lead an experimental 
design to have false negative results.33-34  
The formation of S. Enteritidis H4267 biofilms has not been investigated and can 
provide insights to the food safety industry. Biofilm-producing abilities must be 
investigated to better understand this serotype. Biofilm formation on stainless steel is of 






S. Enteritidis H4267 is hypothesized to be able to form biofilms. Previous work 
indicates that Salmonella biofilm phenotypes display curli and cellulose production.5, 21, 25 
Like other S. Enteritidis serovars, S. Enteritidis H4267 is hypothesized to be able to form 
biofilms on stainless steel surfaces.4, 20 This hypothesis was tested using two phases. 
Phase 1 determined the biofilm-forming ability of S. Enteritidis H4267 utilizing CRA, 
LBAc, and a microtiter assay. Phase 2 investigated the formation of S. Enteritidis H4267 
biofilms on stainless steel discs and removal using sonication.  
 
3. Methods 
3.1. Materials  
Congo Red powder was a product of Alfa Aesar (Haverhill, MA). Brain Heart 
Infusion broth and Luria Broth Agar (LBA) pre-made powders were from Becton 
Dickinson & Company (Franklin Lakes, NJ). Bacteriological peptone used for 0.1% 
(w/v) peptone water (PW) was also from Becton Dickinson. Powdered agar and 
calcofluor (fluorescent brightener #28) were from Sigma-Aldrich Corp. (St. Louis, MO). 
Sucrose, acetic acid, and glass microscope slides were from Thermo Fisher Scientific 
(Waltham, MA). Phosphate buffered saline (PBS) was purchased from Thermo Fisher 
Scientific as a 10X-strength powder and was diluted to be 1X strength in deionized water 
(diH2O). The pH of PBS after dilution was determined using an Accumet AE150 pH 
meter (Thermo Fisher Scientific). Tryptic soy broth (TSB) and tryptic soy agar (TSA) 
were purchased as pre-made powders from Remel Inc. (San Diego, CA) and rehydrated 
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in 1 l of diH2O prior to autoclave sterilization. Crystal violet (CV) solution was also from 
Remel. Ethanol (200 proof) was from Decan Laboratories Inc. (King of Prussia, PA). 
Petri plates were from VWR International (Radnor, PA). Conical tubes and 96-well 
microtiter plates were from Corning Inc. (Corning, NY). Stainless steel 316 discs were 
from BioSurface Technologies Corp. (Bozeman, MT) and were 0.5” diameter, 0.14” 
height/thickness, and 1.0 g weight. 
 
3.2. Bacterial culture  
S. Enteritidis H4267 was obtained from the Department of Food Science culture 
collection at the University of Tennessee (Knoxville, TN) and was maintained at -20ºC in 
25% glycerol. The strain was transferred two times in TSB with 22±2 h incubation at 
37ºC prior to use.  
 
3.3. Determination of curli production of S. Enteritidis H4267 via CRA 
The procedure for determination of curli production using CRA was adapted from 
Freeman et al.35 and Hassan et al.36 Congo Red stain was created by dissolving 5 g/l of 
Congo Red powder in 1 l of diH2O and autoclaving the mixture prior to use.
35 The CRA 
base was created by dissolving 37 g/l of Brain Heart Infusion powder, 50 g/l of sucrose, 
and 10 g/l of agar powder in 1 l of diH2O.
35 After the CRA base mixture was cooled to 
≤55°C, 0.8 g/l of Congo Red was aseptically added using the Congo Red stain to create 
the CRA.35-36 The CRA was stirred for 1 min on a stir plate to create a homogenous 
solution prior to pouring into Petri plates. One hundred µl of S. Enteritidis H4267 (~106 
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CFU/ml) was spread plated onto CRA plates, and plates were inverted and incubated at 
37°C for 22±2 h. Plates were then visually assessed for the appearance of dry, dark 
brown colonies that are indicative of curli-production on CRA.37-38 Plates were completed 
in duplicate and triplicated (n=2, N=6).   
  
3.4. Determination of cellulose-binding production of S. Enteritidis H4267 via LBAc 
The Uhlich et al.39 method for determining cellulose binding to calcofluor was 
utilized. LBAc was created by dissolving 30.5 g/l of LBA powder in 1 l of diH2O and 
dissolving 200 mg/l of calcofluor prior to autoclaving.39 One hundred µl of S. Enteritidis 
H4267 (~106 CFU/ml) was spread plated onto LBAc plates. Plates were inverted and 
incubated at 37°C for 22±2 h and were visually assessed for the appearance of white to 
off-white colonies. Plates were then exposed to long-wave UV light (365 nm) using a 
handheld UV lamp (Model ENF-280C, Spectronics Corp., Westbury, NY) to observe 
fluorescence which is indicative of cellulose binding to calcofluor.39 Plates were 
completed in duplicate and triplicated (n=2, N=6).   
 
3.5. Determination of biofilm formulation of S. Enteritidis H4267 via crystal violet 
assay 
The procedure for determining the presence of biofilms from S. Enteritidis H4267 
was adapted from O’Toole29 and Merritt et al.30 A 0.1% (w/v) CV solution was created 
using CV and sterile diH2O. One hundred µl of S. Enteritidis H4267 (~10
7 CFU/ml) was 
transferred to a well in a 96-well microtiter plate. The negative control utilized was sterile 
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TSB. Plates were covered and incubated at 37°C for 24 h. Planktonic bacteria were then 
removed from the wells by dispensing the liquid into a waste receptacle in a biosafety 
cabinet. Plates were rinsed in sterile diH2O, and the excess diH2O was discarded. Plates 
were tapped to remove residual diH2O remaining in wells, and 125 µl of 0.1% (w/v) CV 
solution was added to each treated well. Plates were incubated at room temperature 
(21±2ºC) for 10 min, and the CV solution was discarded. Plates were tapped to remove 
residual CV solution in the wells prior to undergoing two successive rinses in sterile 
diH2O to remove any residual CV solution. Plates were air dried inside a biosafety 
cabinet for 24 h at room temperature (21±2ºC). After air-drying, plates were visually 
assessed for CV-staining on microtiter walls. Each replicate had six treatment wells and 
were completed in triplicate (n=6, N=18).  
 
3.6. Quantification of the extent of S. Enteritidis H4267 biofilm formation on 
microtiter walls by CV assay 
The development of S. Enteritidis H4267 biofilms on microtiter well surfaces was 
adapted from O’Toole31 and Merritt et al.30 A 30% (v/v) acetic acid solution for 
solubilizing the CV stain was created using acetic acid and sterile diH2O. One hundred µl 
of S. Enteritidis H4267 (~107 CFU/ml) was transferred to a well in a 96-well microtiter 
plate. The negative control utilized was sterile TSB. Plates were held at 37°C for 0, 6, 12, 
18, 24, or 48 h prior to undergoing CV staining described in the biofilm formation via CV 
assay section. After air-drying for 24 h at room temperature (21±2ºC), wells had 200 µl 
of 30% (v/v) acetic acid added to solubilize the CV present on the well walls. The acetic 
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acid was drawn up into a pipet tip and dispensed back into the well five times to create a 
homogeneous mixture of solubilized CV in acetic acid.30 Plates then underwent an optical 
density (OD) reading at 630 nm (OD630nm) using a Synergy HT Microplate Reader 
(BioTek Instruments, Inc., Winooski, VT). The negative control for OD630nm readings 
was 30% (w/v) acetic acid. Each replicate had five treatment wells and were completed in 
triplicate (n=5, N=15). The attachment of S. Enteritidis H4267 to microtiter walls was 
indirectly quantified using the OD630nm absorbance values. 
 
3.7. Preparation of S. Enteritidis H4267 inoculum 
Ten milliliters of an overnight culture of S. Enteritidis H4267 was aliquoted into a 
15 ml conical tube and centrifuged (Centrifuge 5804 R, Eppendorf, Hamburg, Germany) 
at 1372 x g for 15 min. The supernatant was discarded, and 10 ml of PBS was added to 
the conical tube. The tube was vortexed to resuspend and disperse the pellet. The 
resuspended pellet underwent centrifugation again, and the process was repeated two 
more times with PBS to have a total of three washes. After the third wash, the supernatant 
was discarded, and the pellet was re-suspended in 10 ml of sterile 0.1% (w/v) PW.  
 
3.8. Creation of S. Enteritidis H4267 biofilms on stainless steel disc surfaces  
Ten microliters of S. Enteritidis H4267 culture (5.7±0.1 log10 CFU/ml) from the 
prepared inoculum in Section 3.6 was inoculated into 10 ml TSB tubes and vortexed. One 
sterile stainless steel disc was added to tubes. Tubes were statically incubated at 37°C and 
were collected at 0, 6, 12, 18, 24, and 48 h time points. This process was completed in 
137 
 
triplicate (n=1, N=3). The S. Enteritidis H4267 inoculum was also spread plated on TSA 
at 0 h to verify ingoing concentration to TSB tubes. The negative control was sterile TSB 
tubes containing discs.  
 
3.9. Sonication as the removal method for S. Enteritidis H4267 biofilms formed on 
stainless steel disc surfaces  
At each time point, the TSB broth was transferred to a sterile, labeled tube. The 
disc was aseptically transferred using sterile forceps to a sterile Petri dish containing 20 
ml of 0.1% (w/v) PW to remove any loosely attached cells from the disc surface. The disc 
underwent two successive rinses in sterile 0.1% PW to have a total of three washes. After 
the third wash, discs were placed in a conical tube containing 9.0 ml of 0.1% PW. 
Conical tubes containing discs were placed in a tube rack in an ice water bath for 
sonication. The sonicator probe (Vibra Cell VC750 with CV33 probe, Sonics & 
Materials, Inc., Newtown, CT) was submerged 2 mm below the medium surface in the 
conical tube, and the tubes underwent sonication (25% power, 5 kHz) for either 0, 0.5, 1, 
3, or 5 min to dislodge the attached organisms on the disc surface. The sonicator probe 
was cleaned with 70% ethanol and rinsed with sterile diH2O prior to use in another 
sample. The negative control were discs that did not undergo sonication (0 min).  
 
3.10. Enumeration of S. Enteritidis H4267 post-sonication 
The collected TSB and the PW containing the sonicated disc were serially diluted 
in 0.1% PW and spread plated onto TSA for enumeration. Discs that did not undergo 
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sonication (0 min) were rinsed, placed in 9.0 ml of 0.1% PW, and spread plated onto TSA 
plates for enumeration. Plates were inverted and incubated at 37°C for 22±2 h. Microbial 
count data were logarithmically (base 10) transformed. An optimal sonication time length 
was defined to be the sonication time that was shortest and provided a colony count that 
did not display indications of causing cell death due to prolonged sonication exposure.  
 
3.11. Visual observation of cell suspensions of S. Enteritidis H4267 in TSB and 0.1% 
PW containing the sonicated disc 
After spread plating for enumeration, the collected TSB and 0.1% PW containing 
the sonicated disc was utilized for a wet mount. One 10 µl loopful of either TSB or 0.1% 
PW were transferred to a heat-fixed, glass microscope slide and viewed under a phase 
contrast upright microscope (Fisherbrand, Thermo Fisher Scientific). Clustered and 
individual colonies present were recorded, and the microscope stage was moved to 
another section of the sample to record observations. This process was repeated to have a 
total of five viewed images within a sample and was repeated for all triplicates (n=5, 
N=15).  
 
3.12. Visual observation of removal efficacy of biofilms formed on stainless steel disc 
surfaces using a CV staining method 
After an optimal sonication time length was determined, experiments were 
conducted to visually determine the extent of biofilm removal from stainless steel discs 
and to ensure that rinsing in 0.1% PW was sufficient at removing planktonic cells on disc 
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surfaces. S. Enteritidis H4267 biofilms on stainless steel surfaces were grown in TSB 
with a stainless steel disc as mentioned in the biofilm creation on stainless steel discs 
section. Discs were removed from the TSB after 0, 6, 12, 18, 24, and 48 h, and underwent 
separate treatments. Discs were either not rinsed and not sonicated (NR-NS), rinsed three 
times with 0.1% PW but not sonicated (R-NS), or rinsed three times with 0.1% PW and 
sonicated prior to being placed in 0.1% CV solution for 10 min (R-S). After 10 min, discs 
were rinsed two times with sterile 0.1% PW to remove residual CV on the surface. Discs 
were then placed in a sterile Petri dish and allowed to dry at room temperature (21±2ºC) 
for 24 h prior to observations.  
 
3.13. Solubilization using 30% acetic acid of CV-stained stainless steel discs for biofilm 
removal methodology efficacy  
After drying for 24 h at room temperature (21±2ºC), experiments were conducted 
to indirectly determine the extent of biofilm removal from stainless steel discs. Stained 
discs were placed into a sterile conical tube, and 1 ml of 30% (v/v) acetic acid was added 
to the tube. The tubes were vortexed for 5 sec every 2 min for a total of 10 min to ensure 
disc surfaces were exposed to acetic acid. After 10 min, 200 µl of the liquid was 
transferred to a well in a 96-well plate. This was repeated to have two samples per disc 
(n=2, N=6). Plates were measured for OD630nm using a Synergy HT Microplate Reader. 




3.14. Statistical analyses 
Logarithmically transformed enumeration data and absorbance readings were 
analyzed using one-way ANOVA to identify statically significant differences (α = 0.05). 
Significant differences were determined using Tukey’s test (p<0.05). Analyses were 
conducted using SAS v9.4 (SAS Inc., Cary, NC, USA).  
 
4. Results 
4.1. S. Enteritidis H4267 biofilm-forming abilities via CRA, LBAc, and microtiter walls 
S. Enteritidis H4267 displayed red, dry, and rough (“rdar”) colonies on CRA after 
incubation (Figure 3.1) (All tables and figures are located in the appendix of this 
chapter). After incubation at 37°C for 24 h, white colonies were present on LBAc plates. 
When LBAc plates were exposed to long-wave UV light, colonies fluoresced to be bright 
blue (Figure 3.1). After CV-staining, purple lines were present on the walls of S. 
Enteritidis H4267-treated wells (Figure 3.2).   
 
4.2. Quantification of the extent of S. Enteritidis H4267 biofilm formation on 
microtiter walls over time  
Solubilization of the CV dye via 30% acetic acid indicated that the extent of 
biofilm formation increases gradually over time (p=0.002) (Figure 3.3). The 30% acetic 
acid measurement at 48 h was significantly higher than other 30% acetic acid control 
time points (p<0.0001). This is believed to be due to the presence of air bubbles in the 
microtiter wells after being homogenized prior to OD630nm readings. At 48 h, three wells 
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displayed well-bottom CV staining, causing the 48 h time point to be significantly 
different compared to the other S. Enteritidis H4267-treated wells (p<0.0001). A q-test, 
where each time point of a replicate was averaged, was conducted to determine if the 
three wells at 48 h were outliers, but there were no outliers in time points at 90%, 95%, 
and 99% confidence (data not shown). The three wells at 48 h were identified as not 
being outliers, and the values recorded were not adjusted.  
 
4.3. Enumeration of S. Enteritidis H4267 post-sonication 
The 0.5 and 1 min sonication times resulted in the highest recovery of S. 
Enteritidis H4267 after 48 h (Figure 3.4). All sonicated discs were equivalent in recovery 
at 0 and 12 h, but greater recovery counts were seen at 6 h with 0.5 min sonication (Table 
3.1). While 3 and 5 min sonication times were still able to recover S. Enteritidis H4267 
from stainless steel discs, the bacterial counts using 3 and 5 min sonication times were 
significantly lower (p<0.0001) than the 0.5 and 1 min sonication times after 18 h. At 48 
h, 0, 3, and 5 min sonicated discs were different (p<0.0001) from 0.5 and 1 min 
sonication treatments. The 0.5 and 1 min sonication times were the closest in bacterial 
count to the TSB levels at each time point after 6 h. The 0.5 min sonication time length 
for biofilm removal from stainless steel discs was chosen for further experimentation due 




4.4. Visual observation of cell suspensions of S. Enteritidis H4267 in TSB and 0.1% 
PW containing the sonicated disc 
When viewing wet mount images of the 0.1% PW that contained the sonicated 
disc, the number of bacterial clusters increased over time (Figure 3.4). When compared 
to the TSB that contained the stainless steel disc, more individual cells are observed as 
being present in TSB than in 0.1% PW (Figure 3.5). After 0 h, bacterial clusters were 
visible in both 0.1% PW and TSB. After 18 h, the percentage of clustered and individual 
cells in PW and TSB were not statistically different (p<0.0001). 
 
4.5. Removal efficacy of biofilms formed on stainless steel disc surfaces  
After discs that were stained with CV dried at room temperature (21±2ºC) for 24 
h, stained discs were evaluated for visible CV-staining. The NR-NS discs displayed the 
most visible CV-staining after 12 h with a slight purple-blue color being present on disc 
surfaces (Figure 3.6). Discs that were R-NS began to show a faint purple-blue color at 24 
h. The R-S discs displayed no visible presence of CV staining on disc surfaces after 48 h. 
From a visual observation, rinsing with PW removes residual matter from the disc surface 
with rinsing and sonication causing further removal of residual surface matter.  
The CV-stained discs underwent solubilization in 30% acetic acid after visual 
assessment. All treatments were similar to the 30% acetic acid control at 0 h (Figure 3.7). 
The NR-NS disc had the highest absorbance value, indicating that this series of discs had 
the greatest bacterial presence on the disc surface. After 18 h, the R-NS discs were not 
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statistically different from NR-NS discs (p<0.0001). The R-S discs were the closest 
treatment to the control.  
 
5. Discussion 
Cellulose production by S. Enteritidis H4267 was exhibited by the rdar phenotype 
on CRA plates and white colonies on LBAc fluorescing under long-wave UV light. The 
rdar phenotype displayed on CRA plates is indicative of curli and cellulose production, 
particularly for Salmonella spp..5, 22-23, 35-36 If an organism can produce cellulose, colonies 
present on LBAc plates will fluoresce under a long-wave UV light source.
22-23 Calcofluor 
dye fluoresces under long-wave UV light when the dye binds to polysaccharides 
containing (1,3)- or (1-4)-β-D-glucopyranosyl units, such as cellulose.23 
The location of CV staining on the microtiter walls is indicative of aerobic 
growth, which can be expected since S. Enteritidis is a facultative anaerobic 
microorganism.29-30 Using CV staining, Keelara et al. found that 13 different Salmonella 
serotypes were able to form biofilms on microtiter walls while Agarwal et al. showed that 
150 Salmonella serotypes, including S. Enteritidis, have increased biofilm formation after 
24 h on microtiter walls.40-41 Anaerobic bacteria, such as P. aeruginosa, have displayed 
biofilm presence on the bottom of microtiter wells after 24, 48, and 72 h of incubation 
with CV staining.42 At 48 h, CV staining was present on the bottom of three microtiter 
wells, indicating that S. Enteritidis H4267 was precipitating to the bottom of the well 
and/or was utilizing facultative anaerobic growth.29-30 When grown in glass culture tubes, 
S. Pullorum formed biofilms at both the air-liquid interface and settled on the bottom of 
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the tube when incubated at 37°C for 48 h.43 The last stage of biofilm development is 
detachment, so clusters of S. Enteritidis H4267 can detach from microtiter walls over 
time.44-45 S. Enteritidis biofilms have been shown to detach in clusters of aggregated cells 
after extended time, which can explain the increased sedimentation in the bottom of wells 
at 48 h.20  
As sonication times increased, there was a lower bacterial recovery at 18, 24 and 
48 h compared to the shorter 0.5 and 1 min sonication times. Extended sonication times 
can cause a reduction in recovered biofilms, so shortening sonication time was 
anticipated to have reduced cell death.34, 46-47 When S. Anatum was exposed to sonication 
(100% power, 40 kHz) for 3 and 6 min, bacterial counts indicated that recovered cells 
were over 1.0 log10 CFU/cm
2 lower after 3 min sonication and more than 2.0 log10 
CFU/cm2 lower for 6 min treatments than the non-sonicated control.48 After 5 min of 
sonication (20 kHz), S. Typhimurium levels were reduced by over 50% while 
Streptococcus faecalis and Enterococcus faecalis, both Gram-positive bacteria, were only 
lowered by approximately 30%, but there was no cell count investigated to determine the 
log10 CFU/ml reduction.
49  Gram-negative bacteria are also more susceptible to 
sonication than Gram-positive ones.34, 50 Gram-positive bacteria have extensive 
peptidoglycan and teichoic acid cross-links that cause the cell wall to be more robust and 
resistant to ultrasound.50 Reducing the sonication exposure and power level of ultrasound 
frequency are recommended for dislodging bacteria from surfaces while simultaneously 
not causing cell death.51 
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The increasing level of biofilm development over time has caused the gradual 
increase in clustered cells present in 0.1% PW and TSB. As biofilm stage progresses, 
accumulation of bacterial population in the biofilm occurs.52 Sonication disrupts the 
biofilm structure present on disc surfaces, and pieces and individual bacterial cells are 
removed from biofilms.33-34 The S. Enteritidis H4267 clusters found in the TSB after 0 h 
most likely originate from a biofilm, but the biofilm could be on the stainless steel or 
from the culture tube walls near the air-liquid interface. S. Enteritidis biofilms can form at 
the liquid-air interface in culture tubes, and cell aggregates can be present in the culture 
fluid.21, 53 Based on the biofilm enumeration data, biofilms are also being formed on 
stainless steel disc surfaces as early as 6 h after incubation. The microscopy data support 
the notion that biofilms on either glass or stainless steel discs could be reaching the 
“detachment” phase of biofilm development, and clustered communities of S. Enteritidis 
H4267 would be detaching from the main biofilm.20, 44-45 This also supports the 
conclusion that the bottom-stained wells at 48 h were from an accumulation of detaching 
S. Enteritidis H4267 aggregates. Austin et al.20 found that S. Enteritidis biofilms had cell 
aggregates detach from stainless steel surfaces over time. As microbial counts are 
reported in “colony” forming units, clustered cells could result in an underestimation of 
bacterial load since standard counting procedures do not take clusters of cells into 
account.54  
Rinsing surfaces prior to biofilm removal is a common experimental method 
utilized to ensure that the recovered cells are coming from the biofilm and not planktonic 
cells.20, 28, 55-57 Since CV can stain viable and non-viable cells, there is not enough 
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information to determine if the CV stain present on the disc surfaces was biofilms 
containing viable or non-viable S. Enteritidis H4267 communities.30-31 The R-S discs 
being the closest rinse and/or sonication treatment to the 30% acetic acid control further 
supports the experimental method of utilizing stainless steel disc rinsing with 0.1% PW to 
remove residual bacterial cells and sonication to dislodge any bacterial presence on disc 
surfaces. By rinsing discs prior to sonication, the bacterial cells in the 0.1% PW 




S. Enteritidis H4267 displayed the rdar phenotype indicative of Salmonella spp. 
on CRA and had colonies fluoresce on LBAc plates when exposed to long-wave UV 
light. Both methods indicated the curli- and cellulose-forming abilities of S. Enteritidis 
H4267. Microtiter assays demonstrated biofilm formation on microtiter cell walls as early 
as 6 h of incubation at 37°C with CV solubilization demonstrating increased biofilm 
formation over 48 h. Biofilms formed on stainless steel discs and were removed from the 
discs with minimal cell death when rinsed and sonicated in 0.1% (w/v) peptone water 
(PW) for 30 sec (25% power, 5 kHz). This research demonstrates that S. Enteritidis 
H4267 can form biofilms on microtiter well walls and stainless steel surfaces, which has 
not been shown previously. Biofilms can also be effectively removed from stainless steel 
disc surfaces with rinses in 0.1% PW followed by 30 sec of sonication at 25% power in 
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Table 3.1. Enumeration of stainless steel discs that were sonicated at various times 
after being immersed in S. Enteritidis H4267 in tryptic soy broth for various 
incubation times. a 
Incubation time (h) Sonication time (min) b, c Log10 CFU/ml or g d 
0 
0 <1.0 est. e (A0) 
0.5 0.3±0.1 est. (A0) 
1 0.3±0.5 est. (A0) 
3 <1.0 est. (A0) 
5 <1.0 est. (A0) 
6 
0 0.3±0.5 est. (B6) 
0.5 1.5±0.3 est. (A6) 
1 0.8±0.6 est. (AB6) 
3 0.3±0.2 est. (AB6) 
5 0.0±0.0 est. (AB6) 
12 
0 2.5±0.1 (B12) 
0.5 4.8±0.5 (A12) 
1 4.8±0.1 (A12) 
3 4.6±0.3 (A12) 
5 4.6±0.1 (A12) 
18 0 4.1±0.1 (C18) 
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Table 3.1 Continued 
18 (Cont.) 
  
0.5 5.3±0.5 (A18) 
1 5.2±0.0 (A18) 
3 4.7±0.2 (B18) 
5 4.7±0.1 (B18) 
24 
0 4.5±0.0 (C24) 
0.5 5.9±0.0 (A24) 
1 5.9±0.1 (A24) 
3 5.0±0.0 (B24) 
5 4.9±0.1 (B24) 
48 
0 4.7±0.0 (B48) 
0.5 6.0±0.2 (A48) 
1 5.7±0.3 (A48) 
3 4.9±0.0 (B48) 
5 4.8±0.1 (B48) 
a Stainless steel discs were immersed in tryptic soy broth during incubation and were 
sonicated in 0.1% (w/v) peptone water prior to enumeration on tryptic soy agar plates.   
b Samples were sonicated at 25% power (5 kHz) in 0.1% (w/v) peptone water for 30 
sec. 
c Negative control was 0 min, positive control was the tryptic soy broth medium the 




Table 3.1 Continued 
d Different letters indicate significantly different (α=0.05) means when comparing 
sonication time treatment at each time point. Subscript indicates the incubation hour for 
ease of comparing different letters.  
e Samples that had <25 CFU/g or ml on tryptic soy agar after 22±2 h incubation at 37°C 







Figure 3.1. S. Enteritidis H4267 growth on Congo Red Agar (CRA) and Luria Broth agar with 0.02% (w/v) calcofluor 
(LBAc) plates. S. Enteritidis H4267 growth on CRA (left) indicating red, dry, and rough colonies and on LBAc (right) indicating 














Figure 3.2. Biofilm formation of S. Enteritidis H4267 on microtiter well walls. S. Enteritidis H4267 visible on microtiter well 
walls after staining with a 0.1% (w/v) crystal violet (CV) solution. Stained wells are from S. Enteritidis H4267 treated wells that 
were aerobically incubated for 24 h at 37°C. Treated wells had S. Enteritidis H4267 removed and washed from the well for CV 












Figure 3.3. Solubilization of crystal violet (CV)-stained S. Enteritidis H4267 biofilms in microtiter wells. Extent of S. 
Enteritidis H4267 over time on microtiter well walls after staining with 0.01% (w/v) CV dye and solubilization of dye in 30% 
(v/v) acetic acid. Stained wells are from S. Enteritidis H4267 treated wells that were aerobically incubated at 37°C for 6 to 48 h. 
Treated wells had S. Enteritidis H4267 removed and washed from the well for CV staining before being dried at room 
temperature (21±2°C) for 24 h, and CV stain was solubilized in 200 microliters of 30% acetic acid for 10 min (n=5, N=15). Insert 
image is of microtiter plates after 6 (top), 12 (second from top), 18 (middle), 24 (second from bottom), and 48 (bottom) h of 


































Figure 3.4. Recovered S. Enteritidis H4267 from tryptic soy broth (TSB) and biofilms formed on stainless steel discs.  S. 
Enteritidis H4267 recovered from TSB or stainless steel discs sonicated in 0.1% (w/v) peptone water for various lengths of time. 















































Figure 3.5. Clustered and individual S. Enteritidis H4267 cells from sonicated stainless steel discs. Distribution of individual 
versus clustered cells of S. Enteritidis H4267 recovered from sonicated stainless steel discs in 0.1% (w/v) peptone water viewed 
via wet mount. Stainless steel discs were statically incubated at 37°C in tryptic soy broth inoculated with S. Enteritidis H4267 






















Figure 3.6. Clustered and individual S. Enteritidis H4267 cells from collected tryptic soy broth (TSB) and 0.1% peptone 
water (PW). Clustered and individual cells of  S. Enteritidis H4267 recovered from TSB and sonicated stainless steel discs in  
0.1% (w/v) PW viewed via wet mount. Stainless steel discs were statically incubated at 37°C in TSB inoculated with S. Enteritidis 

























Figure 3.7. Discs stained with crystal violet after S. Enteritidis H4267 biofilm 
growth and various rinsing and sonication methods. Crystal violet stained discs at 0, 
6, 12, 18, 24, and 48 hours when a) not rinsed and not sonicated, b) rinsed three times in 
0.1% (w/v) peptone water (PW) and not sonicated, and c) rinsed three times in 0.1% PW 
and sonicated for 30 seconds in 9 ml of 0.1% PW. 






Figure 3.8. Solubilized crystal violet from S. Enteritidis H4267 biofilms on stainless steel discs after various rinsing and 
sonication methods. Absorbance of 30% (v/v) acetic acid from stainless steel discs that were either rinsed and sonicated (RS), 





























Chapter 5. Determination of antimicrobial activity of microemulsions 
containing cinnamon and orange oil on Salmonella Enteritidis H4267 





Antimicrobial delivery systems to combat S. Enteritidis biofilms in the food 
industry while also avoiding bacterial resistance are of interest. Essential oils (EOs) are 
attractive systems due to being plant-derived, but colloidal systems, such as emulsions, 
are needed for utilization due to EOs hydrophobic characteristics. Micro- and nano-
emulsions were formed with, on mass ratio, 0 to 2% sunflower lecithin (SL), 3.3 to 20% 
Tween® 20 or Tween® 80, cinnamon oil (CO, Cinnamomum zeylanicum) and orange oil 
(OO, Citrus sinensis) in a 9:1 volume ratio, and deionized water. After treatment for 5 
min at room temperature (21±2°C), microemulsions composed of 0 or 2% SL, 5% CO-
OO, and 20% Tween 20 had the highest antimicrobial activity against S. Enteritidis 
H4267 biofilms formed on stainless steel discs over 48 h. After 18 h, 2% SL, 5% CO-
OO, 20% Tween 20 microemulsions had the greatest antimicrobial activity against S. 
Enteritidis H4267 biofilms (p<0.0001). Due to the limitations of time points tested, 
determining whether emulsion size or surfactant addition affected antimicrobial ability 
the most could not be determined. However, this study proves that microemulsions 
composed of CO-OO can have bactericidal activity against S. Enteritidis H4267 biofilms 
present on stainless steel surfaces. This study shows that co-encapsulated EOs in 
microemulsions could be developed for antimicrobial delivery systems to treat biofilms. 
 
1. Introduction 
As microorganisms proliferate, extracellular polymeric substances (EPS) are 
excreted, encasing the biofilm in a scaffolding matrix.1 Complexities within the 
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extracellular matrix of the biofilm arise with continued proliferation, leading to biofilm 
maturation. This EPS layer can provide an increased extrinsic defense for the biofilm by 
forming a “coat” on the exterior portion of the biomass of cells.2 As more EPS are 
produced, channels and pores begin to form within the biofilm, creating a highway for 
transporting water, oxygen, and nutrients throughout the biofilm while excreting waste 
products from the interior portion.3-5 
Increased resistance to sanitizers and medical antibiotics is also a characteristic of 
biofilms.2, 6-7 Sessile cells contained within a biofilm can become more resistant to 
sanitizing or antimicrobial methods than their planktonic counterparts due to the 
decreased metabolism.2, 8-12 Permeability through the complex biofilm matrix may also be 
related to the amount of biofilm biomass density; the higher the cell density, the lower the 
diffusion 2, 13-14  When comparing various strains of S. Typhimurium, EPS-producing 
strains in biofilms had higher resistance to quaternary ammonium compounds and 
chlorine sanitizing solutions compared to planktonic cells.8 
Antimicrobial delivery systems to combat biofilms in the food industry while also 
avoiding bacterial resistance to disinfectants are of interest.15 Plant-derived essential oils 
(EOs) are an attractive option for antimicrobial systems as EOs do not contribute to drug 
resistance due to the current mechanism of action focusing on the disruption of bacterial 
membranes.16-19 The hydrophobicity of EOs allows the oils to penetrate through a 
bacterial cell membrane and causes a disruption of cellular metabolic processes and 
membrane transport systems17-18 The cell membrane integrity will ultimately breakdown 
and cause increased membrane permeability.17-18 Cinnamon oil (CO) has been researched 
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extensively as an antimicrobial agent against a variety of bacteria, including Salmonella 
and has demonstrated enhanced antimicrobial activity against S. Enteritidis in the 
presence of other EOs.20-32 Orange oils (OOs) have exhibited antimicrobial activity 
enhancement of other EOs when used in combination against Salmonella spp.33-35 A 
limiting factor for the usage of EOs is their hydrophobic characteristic, and colloidal 
systems, such as emulsions, are needed for utilization.  
Colloidal systems with nanoscale oil droplets have unique features that are not 
found in conventional emulsions.36-37 Nanoemulsions have droplet diameters between 20 
and 200 nm while microemulsions have oil droplet dimensions between 4 and 100 nm.36 
Although nanoemulsions and microemulsions have overlapping dimensions, 
microemulsions are thermodynamically stable oil-water-surfactant mixtures that are 
transparent, and nanoemulsions are metastable systems that can be clear or turbid in 
appearance36, 38 Due to having a small droplet size and large surface area, microemulsions 
can penetrate through bacterial cell walls more efficiently, which can increase the 
antimicrobial activity.39 While there are several benefits of microemulsions, 
microemulsions are formed only at a particular set of conditions and require a relatively 
high level of surfactants.36-37 Despite these drawbacks, the oil body of microemulsions 
can be used to dissolve lipophilic compounds, which could be an approach to enhance 
antimicrobial activity. 40-41 Microemulsions with multiple-component oil phase have also 
been created and could be utilized for biofilm treatment.40-41  
Due to the complexity of biofilms, microemulsions that have activity against 
planktonic cultures may not have activity against a formed biofilm. Additionally, droplet 
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size is of importance for biofilm treatment to determine if a nanoemulsion would also be 
able to have an antimicrobial effect on biofilms or if a microemulsion is more 
appropriate. The application of a microemulsion composed of a mixture of CO and OO 
(CO-OO) on S. Enteritidis H4267 biofilms formed on stainless steel disc surfaces is of 




The hypothesis was that microemulsions containing CO and OO will have a 
greater antimicrobial effect on S. Enteritidis H4267 biofilms compared to control 
emulsions of a larger droplet size. The addition of surfactants can cause a reduction in 
emulsion antimicrobial activity and higher oil levels could be needed to overcome this 
barrier.22, 24, 42-44 Because of the small droplet size, microemulsions should have greater 
bioavailability and could have higher antimicrobial ability compared to other emulsions 
with larger droplets.32, 36, 45-47  
This hypothesis was tested in two phases. Phase 1 created two types of controls; 
one set of controls contained surfactants without CO and OO and another set of controls 
contained CO and OO but were not microemulsions. Once Phase 1 was completed, Phase 
2 investigated the antimicrobial effects emulsion treatments on biofilms formed on 





3.1. Materials  
Bacteriological peptone used for 0.1% (w/v) peptone water (PW) was from 
Becton Dickinson & Company (Franklin Lakes, NJ). Phosphate buffered saline (PBS) 
was purchased from Thermo Fisher Scientific (Waltham, MA) in a 10X-strength powder 
and was diluted to be 1X strength in deionized water (diH2O). The pH of PBS after 
dilution was determined using an Accumet AE150 pH meter (Thermo Fisher Scientific). 
Tryptic soy broth (TSB) and tryptic soy agar (TSA) were purchased as pre-made powders 
from Remel Inc. (San Diego, CA) and rehydrated in 1 l of diH2O prior to autoclave 
sterilization. Ethanol (200 proof) was from Decan Laboratories Inc. (King of Prussia, 
PA). Petri plates were from VWR International (Radnor, PA). Conical tubes and 96-well 
microtiter plates were from Corning Inc.  (Corning, NY). Cinnamon oil (CO, 
Cinnamomum zeylanicum) was a product of Sigma-Aldrich Corp. (St. Louis, MO). 
Orange oil (OO, Citrus sinensis) was purchased from Now Essential Oil, Co. 
(Bloomingdale, IL). Tween 20 and Tween 80 were both products of Acros Organics 
(Morris Plains, NJ), and sunflower lecithin (SL) was purchased from Perimondo LLC 
(New York, NY). Stainless steel 316 discs were from BioSurface Technologies Corp. 
(Bozeman, MT) and were 0.5” diameter, 0.14” height/thickness, and 1.0 g weight.  
 
3.2. Bacterial culture  
S. Enteritidis H4267 was obtained from the Department of Food Science culture 
collection at the University of Tennessee (Knoxville, TN) and was maintained at -20ºC in 
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25% glycerol. The strain was transferred two times in TSB with 22±2 h incubation at 
37ºC prior to use.  
 
3.3. Creation of microemulsions containing CO and OO 
Emulsion preparation followed previous work, with modification for 
compositions.41 Microemulsions had CO and/or OO added to scintillation vials on mass 
basis at 1% to 5% levels along with 20% Tween 20 in CO-OO volume ratio of 9:1. A 
12% stock solution of SL was prepared with diH2O by stirring for 8 h at room 
temperature (21±2ºC) and added to solution vials, on mass basis, at 0% to 2%. Vials were 
added with diH2O to bring the total microemulsion mass to 25.0 g and were hand-agitated 
until visually homogenous, followed by heating in an 80ºC water bath for 5 min. After 
heating, vials were hand-agitated in an ice water bath (5±0.5ºC).  
 
3.4. Creation of controls  
Emulsions to be used as controls against microemulsions were created by 
combining, on mass basis, 0 to 2% SL, 1 to 5% CO-OO in a 9:1 volume ratio, and 3.3 to 
13.3% Tween 80 in a scintillation vial. Controls that did not contain CO-OO were also 
created using, on mass basis, 0 to 2% SL and 20% Tween 20. Vials had diH2O added to 




3.5. Droplet size and zeta (ζ)-potential of control emulsions containing CO and OO 
Droplet size. Droplet size distribution of control emulsions were determined using 
dynamic light scattering (Zeta Sizer S, Malvern Panalytical Ltd., Worcestershire, UK) at 
a 173º scattering angle. All emulsions were diluted 100-fold in diH2O to fit instrument 
sensitivity. Measurements were performed three times for each sample, and emulsions 
were created in triplicate (n = 3, N = 9).  
ζ-potential. The ζ-potential of control emulsions was measured using the same 
dynamic light scattering instrument utilized for droplet size distribution determination. 
Samples were diluted 100-fold in diH2O and were created in triplicate (n = 3, N = 9). 
 
3.6. Preparation of S. Enteritidis H4267 inoculum  
After S. Enteritidis H4267 was incubated for 22±2 h at 37°C, 10 ml of the culture 
was aliquoted into a 15 ml conical tube and centrifuged (Centrifuge 5804 R, Eppendorf, 
Hamburg, Germany) for 15 min at 1372 x g. After centrifugation, the supernatant was 
discarded, and 10 ml of sterile PBS was added to the conical tube. The pellet was 
resuspended and dispersed into the PBS by vortexing the tube, and the resuspended pellet 
underwent centrifugation again. The process was repeated two more times with sterile 
PBS to have a total of three washes. After the third wash, the supernatant was discarded, 




3.7. Creation of S. Enteritidis H4267 biofilms on stainless steel disc surfaces  
Ten microliters of the prepared-S. Enteritidis H4267 inoculum was diluted to ~107 
CFU/ml and was inoculated into 10 ml TSB tubes. Tubes were vortexed, and 1 sterile 
stainless steel disc was added to tubes. Tubes were statically incubated at 37°C and 
collected at 0, 6, 12, 18, 24, and 48 h time points (n=1, N=3). The S. Enteritidis H4267 
inoculum was also spread plated on TSA at 0 h to verify ingoing concentration to TSB 
tubes.  
 
3.8. Emulsion treatment of S. Enteritidis H4267 biofilms on stainless steel disc surfaces  
At each time point, the TSB broth in the tube was transferred to a sterile, labeled 
tube. To remove loosely attached cells from the disc surface, the disc was aseptically 
transferred using sterile forceps to a sterile Petri dish containing 20 ml of 0.1% (w/v) PW. 
The disc underwent two successive rinses in sterile 0.1% PW for a total of three washes. 
After the final wash, discs were placed in a sterile Petri dish containing 25 ml of either a 
microemulsion or emulsion formulation. Discs were held in the emulsion treatment for 5 
min. After emulsion treatment, discs were aseptically removed and placed in a Petri dish 
containing 20 ml of 0.1% PW. The treated disc underwent an additional rinse to remove 
any residual emulsion present on the surface before being placed into a conical tube 
containing 9.0 ml of 0.1% PW. A control treatment without emulsions was also done 
where discs were collected at each time point, washed with 0.1% PW three times, and 




3.9. Sonication of treated stainless steel discs containing S. Enteritidis H4267 biofilms  
Conical tubes containing discs were placed in a tube rack in an ice water bath for 
sonication. The sonicator probe (Vibra Cell VC750 with CV33 probe, Sonics & 
Materials, Inc., Newtown, CT) was submerged 2 mm below the medium surface in the 
conical tube, and the tubes underwent sonication (25% power, 5 kHz) for 30 sec to 
dislodge the attached organisms on the disc surface. The sonicator probe was cleaned 
with 70% ethanol and rinsed with sterile diH2O prior to use in another sample.  
 
3.10. Enumeration of S. Enteritidis H4267 post-sonication 
The collected TSB and the PW containing the sonicated disc were serially diluted 
in 0.1% PW and spread plated onto TSA for enumeration. Plates were inverted and 
incubated at 37°C for 22±2 h. Microbial count data were logarithmically (base 10) 
transformed.  
 
3.11. Statistical analyses  
Logarithmically transformed enumeration data were analyzed using one-way 
ANOVA to identify statically significant differences (α = 0.05). Significant differences 
were determined using Tukey’s test (p<0.05). Analyses were conducted using SAS v9.4 






4.1. Droplet size distribution and ζ-potential of control emulsions 
 The surfactant control containing 0 or 2% SL and 20% Tween 20 without CO and 
OO had small droplet diameters (Figure 4.1) (All tables and figures are located in the 
appendix of this chapter). Nanoemulsions with 5% CO-OO in a 9:1 volume ratio were 
able to be created using 13.3% (w/w) Tween 80 with 0% or 2% SL. For 1% CO-OO (9:1) 
formulations, Tween 80 had to be reduced to 3.3% (w/w) to obtain an emulsion that was 
not within microemulsion droplet diameter range. The 0% SL, 1% CO-OO (9:1), 6.7% 
(w/w) Tween 80 formulation could be considered a nanoemulsion due to having two 
intensity peaks, but the 3.3% (w/w) formulation was chosen due to having a greater 
droplet distribution intensity between 10 and 200 nm. The ζ-potential for all emulsions 
was slightly negative, with emulsions containing EOs being more negatively charged 
(Figure 4.2).  
 
4.2. Enumeration of S. Enteritidis H4267 after emulsion treatment 
The 0 and 2% SL, 5% CO-OO microemulsions were the only treatments that 
resulted in bactericidal activity at 0 and 6 h (Table 4.1). The 0% SL, 5% CO-OO 
nanoemulsion also had high antimicrobial activity at 6 h but was not bactericidal (Figure 
4.3). After 18 h, the 2% SL, 5% CO-OO microemulsion had the greatest antimicrobial 
effect on biofilm discs (p<0.0001). Control discs that did not undergo an emulsion 






Surfactant presence can hinder the antimicrobial ability of EOs when the latter is 
encapsulated.22, 48 Bacteria have been shown to utilize the oleic acid moiety in Tween 80 
as a carbon and energy source when Tween 80 is above 0.1%.49-51 Levels of Tween 20 
greater than 4% (w/w) of the emulsion solution have shown to act as a nutrient source 
and contribute to planktonic bacterial growth.52-56 Despite these drawbacks, there have 
been studies showing that the presence of Tweens at levels as low as 0.05% were able to 
decrease S. enterica levels from biofilms.57-58 Tween 20 and 80 can promote the dispersal 
of S. enterica cells from biofilms and cause cell aggregates to break into smaller 
aggregates or individual cells, making the cells more susceptible to antimicrobials.57, 59 
Bacterial biofilm formation and cell growth have also been shown to be hindered by CO 
and cinnamaldehyde, a primary component in CO that has antimicrobial and anti-quorum 
sensing properties.22, 60-63 While the addition of lecithin above 1.0% (w/v) contributes to 
microbial growth, lecithin can still play a role in lowering interfacial tension.64-69 When 
phosphatidylcholine, a primary component in lecithin, was combined with other 
surfactants, the mixed system was able to lower the surface tension compared to a single 
surfactant system.68, 70-71  
The stage of biofilm development could explain the slight increase in 
antimicrobial activity seen in a variety of emulsion treatments after 18 h. Salmonella sp. 
biofilms tend to adhere to stainless steel and attach at a fast rate when incubated at 
37°C.72 This has been attributed to the production of curli fibers and fimbriae being 
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affected by low temperatures, which leads to a decreased rate of biofilm development.73 
By 8 h at 37°C, S. Typhimurium can reach the maturation stage of biofilm development, 
and the detachment phase of biofilm development is already in progress by 24 h.72 Pieces 
of a biofilm can detach from the biofilm structure, and this causes the biofilm to be 
exposed to extrinsic factors.74 Antimicrobials can take advantage of this exposure and 
have a greater antimicrobial effectiveness since the EPS layer is no longer intact.74  
The size of the emulsion also played a role in level of antimicrobial activity as 5% 
CO-OO microemulsions were the two formulations that had the highest antimicrobial 
activity over time. The addition of SL and Tween had a role in inhibiting antimicrobial 
ability, as various emulsions and the 1% CO-OO microemulsion had lower antimicrobial 
effect than the no-rinse treatment at several time points. The specific cause of the 
decreased antimicrobial ability is uncertain, whether it be the addition of SL and Tween 
20 or the size of the emulsions. All three factors played a role at a variety of time points 
and convolutes the precise determining factor. Further studies are recommended to 
include more emulsion-exposure time points, imaging of biofilms pre- and post-emulsion 
treatment, and a LIVE/DEAD BacLight assay to determine the level of viable and non-
viable cells will provide more insight on the action taking place.75  
 
6. Conclusion 
Microemulsions composed of 0 or 2% SL, 5% CO-OO, and 20% Tween 20 had 
the highest antimicrobial activity against S. Enteritidis H4267 biofilms formed on 
stainless steel discs over 48 h. The only bactericidal activity seen at both 0 and 6 h were 
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from 5% CO-OO microemulsion formulations. The absence of emulsion treatments that 
lowered microbial levels compared to 1% CO-OO formulations after 0 h indicates that 
the addition of SL and Tween 20 and Tween 80 were unfavorable for the bioactivity of 
1% CO-OO. After 12 h, 0% CO-OO control emulsions were among the highest microbial 
levels. Both 0 and 1% CO-OO results indicate that CO-OO presence at levels above 1% 
were needed for antimicrobial activity. After 18 h, 2% SL, 5% CO-OO, 20% Tween 20 
microemulsions had the greatest antimicrobial activity against S. Enteritidis H4267 
biofilms (p<0.0001). Due to the limitations of time points tested, determining whether 
emulsion size or surfactant addition affected antimicrobial ability the most cannot be 
determined. However, this study proves that microemulsions composed of CO-OO can 
have bactericidal activity against S. Enteritidis H4267 biofilms present on stainless steel 
surfaces and co-encapsulated EOs in microemulsions could be developed for 
antimicrobial delivery systems. 
 
Acknowledgements 
Funding support was provided by USDA NIFA Award 2015-38420-23695 and 
Hatch Projects TEN00487 and 223984. I thank Dr. Tao Wu and Dr. Philipus Pangloli for 





1. Czaczyk, K.; Myszka, K., Biosynthesis of extracellular polymeric substances 
(EPS) and its role in microbial biofilm formation. Polish J Environ Stud 2007, 16 (6), 
799-806. 
2. Chandki, R.; Banthia, P.; Banthia, R., Biofilms: a microbial home. J Indian Soc 
Periodontol 2011, 15 (2), 111-114. 
3. Tolker-Nielsen, T.; Molin, S., Spatial organization of microbial biofilm 
communities. Microbial Ecology 2000, 40 (2), 75-84. 
4. Klausen, M.; Heydorn, A.; Ragas, P.; Lambertsen, L.; Aaes-Jorgensen, A.; Molin, 
S.; Tolker-Nielsen, T., Biofilm formation by Pseudomonas aeruginosa wild type, flagella 
and type IV pili mutants. Molec Microbiol 2003, 48 (6), 1511-1524. 
5. Sauer, K.; Camper, A. K.; Ehrlich, G. D.; Costerton, J. W.; Davies, D. G., 
Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. 
Journal of Bacteriology 2002, 184 (4), 1140-1154. 
6. Lindsay, D.; von Holy, A., Bacterial biofilms within the clinical setting: what 
healthcare professionals should know. J Hosp Infect 2006, 64 (4), 313-25. 
7. Lynch, A. S.; Robertson, G. T., Bacterial and fungal biofilm infections. Annu Rev 
Med 2008, 59, 415-28. 
8. Wang, R.; Kalchayanand, N.; Schmidt, J. W.; Harhay, D. M., Mixed biofilm 
formation by Shiga toxin-producing Escherichia coli and Salmonella enterica serovar 
183 
 
Typhimurium enhanced bacterial resistance to sanitization due to extracellular polymeric 
substances. J Food Prot 2013, 76 (9), 1513-1522. 
9. Arizcun, C.; Vasseur, C.; Labadie, J. C., Effect of several decontamination 
procedures on Listeria monocytogenes growing in biofilms. J Food Prot 1998, 61 (6), 
731-734. 
10. Beresford, M. R.; Andrew, P. W.; Shama, G., Listeria monocytogenes adheres to 
many materials found in food-processing environments. J Appl Microbiol 2001, 90, 
1000-1005. 
11. Ronner, A. B.; Wong, A. C. L., Biofilm development and sanitizer inactivation of 
Listeria monocytogenes and Salmonella typhimurium on stainless steel and Buna-n 
rubber. J Food Prot 1993, 9, 750-758. 
12. Donlan, R. M.; Costerton, J. W., Biofilms: survival mechanisms of clinically 
relevant microorganisms. Clin Microbiol Rev 2002, 15 (2), 167-193. 
13. Ben-Jacob, E.; Garik, P., The formation of patterns in non-equilibrium growth. 
Nature 1990, 343 (6258), 523-530. 
14. Taylor, S. W.; Jaffé, J. R., Biofilm growth and the related changes in the physical 
properties of porous medium. Water Resources Res 1990a, 26 (9), 2161-2169. 
15. Galie, S.; Garcia-Gutierrez, C.; Miguelez, E. M.; Villar, C. J.; Lombo, F., 




16. Kim, Y. G.; Lee, J. H.; Gwon, G.; Kim, S. I.; Park, J. G.; Lee, J., Essential oils 
and eugenols inhibit biofilm formation and the virulence of Escherichia coli O157:H7. 
Sci Rep 2016, 6, 36377. 
17. Langeveld, W. T.; Veldhuizen, E. J.; Burt, S. A., Synergy between essential oil 
components and antibiotics: a review. Crit Rev Microbiol 2014, 40, 76-94. 
18. Sikkema, J.; de Bont, J. A. M.; Poolman, B., Interactions of cyclic hydrocarbons 
with biological membranes. J Biol Chem 1994, 269, 8022-8028. 
19. Davidson, P. M.; Critzer, F. J.; Taylor, T. M., Naturally occurring antimicrobials 
for minimally processed foods. Ann Rev Food Sci Tech 2013, 4 (163-190). 
20. Becerril, R.; Nerín, C.; Gómez-Lus, R., Evaluation of bacterial resistance to 
essential oils and antibiotics after exposure to oregano and cinnamon essential oils. 
Foodborne Pathog Dis 2012, 9 (8), 699-705. 
21. Brnawi, W. I.; Hettiarachchy, N. S.; Horax, R.; Kumar-Phillips, G.; Ricke, S., 
Antimicrobial activity of leaf and bark cinnamon essential oils against Listeria 
monocytogenes and Salmonella typhimurium in broth system and on celery. J Food 
Process Preserv 2019, 43, 1-8. 
22. Chuesiang, P.; Siripatrawan, U.; Sanguandeekul, R.; Yang, J. S.; McClements, D. 
J.; McLandsborough, L., Antimicrobial activity and chemical stability of cinnamon oil in 
oil-in-water nanoemulsions fabricated using the phase inversion temperature method. 
LWT Food Sci Tech 2019, 110, 190-196. 
185 
 
23. Cui, H. Y.; Zhou, H.; Lin, L.; Zhao, C. T.; Zhang, X. J.; Xiao, Z.; Li, C.-Z., 
Antibacterial activity and mechanism of cinnamon essential oil and its application in 
milk. J Animal Plant Sci 2016, 26 (2), 532-541. 
24. Ma, Q.; Davidson, P. M.; Zhong, Q., Antimicrobial properties of microemulsions 
formulated with essential oils, soybean oil, and Tween 80. Int J Food Microbiol 2016, 
226, 20-5. 
25. Olaimat, A. N.; Al-Holy, M. A.; Ghoush, M. H. A.; Al-Nabulsi, A. A.; Osaili, T. 
M.; Holley, R. A., Inhibitory effects of cinnamon and thyme essential oils against 
Salmonella spp. in hummus (chickpea dip) J Food Process Preserv 2019, 43 (5). 
26. Singh, G.; Maurya, S.; deLampasona, M. P.; Catalan, C. A. N., A comparison of 
chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, 
oleoresins and their constituents. Food Chem Toxicology 2007, 45 (9), 1650-1661. 
27. Tsai, H.-C.; Sheng, L.; Zhu, M.-J., Antimicrobial efficacy of cinnamon oil against 
Salmonella in almond based matrices. Food Control 2017, 80, 170-175. 
28. Zhang, L.; Critzer, F.; Davidson, P. M.; Zhong, Q., Formulating essential oil 
microemulsions as washing solutions for organic fresh produce production. Food Chem 
2014, 165, 113-8. 
29. Zhang, Y.; Chen, H.; Critzer, F.; Davidson, P. M.; Zhong, Q., Potential of 




30. Zhang, Y.; Liu, X.; Wang, Y.; Jiang, P.; Quek, S., Antibacterial activity and 
mechanism of cinnamon essential oil against Escherichia coli and Staphylococcus 
aureus. Food Control 2016, 59, 282-289. 
31. Ebani, V. V.; Nardoni, S.; Bertelloni, F.; Tosi, G.; Massi, P.; Pistelli, L.; 
Mancianti, F., In vitro antimicrobial activity of essential oils against Salmonella enterica 
serotypes Enteritidis and Typhimurium strains isolated from poultry. Molecules 2019, 24 
(5). 
32. Raybaudi-Massilia, R. M.; Mosqueda-Melgar, J.; Martin-Bellosi, O., 
Antimicrobial activity of essential oils on Salmonella Enteritidis, Escherichia coli, and 
Listeria innocua in fruit juices. J Food Protec 2006, 69 (7), 1579-1586. 
33. O'Bryan, C. A.; Crandall, P. G.; Chalova, V. I.; Ricke, S. C., Orange essential oils 
antimicrobial activities against Salmonella spp. J Food Sci 2008, 73 (6), M264-M267. 
34. Thanissery, R.; Kathariou, S.; Smith, D. P., Rosemary oil, clove oil, and a mix of 
thyme-orange essential oils inhibit Salmonella and Campylobacter in vitro. J Appl 
Poultry Res 2014, 23 (2), 221-227. 
35. Thanissery, R.; Smith, D. P., Marinade with thyme and orange oils reduces 
Salmonella Enteritidis and Campylobacter coli on inoculated broiler breast fillets and 
whole wings. Poultry Sci 2014, 93, 1258-1262. 
36. McClements, D. J., Edible nanoemulsions: fabrication, properties, and functional 
performance. Soft Matter 2011, 7 (6), 2297-2316. 
187 
 
37. McClements, D. J.; Rao, J., Food-grade nanoemulsions: formulation, fabrication, 
properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr 
2011, 51 (4), 285-330. 
38. Shinoda, K.; Lindman, B., Organised surfactant systems: microemulsions. 
Langmuir 1987, 3, 135-149. 
39. Donsi, F.; Ferrari, G., Essential oil nanoemulsions as antimicrobial agents in food. 
J Biotech 2016, 233, 106-120. 
40. Sharif, H. R.; Goff, H. D.; Majeed, H.; Shamoon, M.; Liu, F.; Nsor-Atindana, J.; 
Haider, J.; Liang, R.; Zhong, F., Physicochemical properties of β-carotene and eugenol 
co-encapsulated flax seed oil powders using OSA starches as wall material. Food 
Hydrocolloids 2017, 73, 274-283. 
41. Chen, H.; Guan, Y.; Zhong, Q., Microemulsions based on a sunflower lecithin-
Tween 20 blend have high capacity for dissolving peppermint oil and stabilizing 
coenzyme Q10. J Agric Food Chem 2015, 63 (3), 983-989. 
42. Hammer, K.; Carson, C.; Riley, T., Influence of organic matter, cations and 
surfactants on antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro. J 
Appl Microbiol 1999, 86 (3), 446-452. 
43. Inouye, S.; Tsuruoka, T.; Uchida, K.; Yamaguchi, H., Effect of sealing and Twen 




44. Remmal, A.; Bouchikhi, T.; Tantaoui-Elaraki, A.; Ettayebi, M., Inhibition of 
antiibacterial activity of essential oils by Tween 80 and ethanol in liquid medium. J 
Pharm Belg 1993, 48 (5), 352-356. 
45. Burt, S., Essential oils: their antibacterial properties and potential applications in 
foods-a review. Int J Food Microbiol 2004, 94 (3), 223-253. 
46. McClements, D. J., Nanoemulsions versus microemulsions: terminology, 
differences, and similarities. Soft Matter 2012, 8 (6), 1719-1729. 
47. McClements, D. J., Enhanced delivery of lipophilic bioactives using emulsions: a 
review of major factors affecting vitamin, nutraceutical, and lipid bioaccessibility. Food 
Funct 2017. 
48. Hofer, A.; Herwig, C.; Spadiut, O., Lecithin is the key material attribute in soy 
bean oil affecting filamentous bioprocesses. AMB Express 2018, 8 (90). 
49. Howe, T. G. B.; Ward, J. M., The utilization of Tween 80 as carbon source by 
Pseudomonas. J General Microbiol 1976, 92, 234-245. 
50. Slijkhuis, H.; van Groenestijn, J. W.; Kylstra, D. J., Microthrix purvicella, a 
filamentous bacterium from activated sludge: growth on Tween 80 as carbon and energy 
source. J General Microbiol 1984, 130, 2035-2042. 
51. Ziani, K.; Chang, Y.; McLandsborough, L.; McClements, D. J., Influence of 
surfactant charge on antimicrobial efficacy of surfactant-stabilized thyme oil 
nanoemulsions. J Agric Food Chem 2011, 59, 6247-6255. 
52. Nielsen, C. K.; Kjems, J.; Mygind, T.; Snabe, T.; Meyer, R. L., Effects of Tween 
80 on growth and biofilm formation in laboratory media. Front Microbiol 2016, 7 (1878). 
189 
 
53. Van Boxtel, R. M.; Lambrecht, R. S.; Collins, M. T., Effects of colonial 
morphology and Tween 80 on antimicrobial susceptibility of Mycobacterium 
paratuberculosis. Antimicrobial Agents Chemo 1990, 34 (12), 2300-2303. 
54. Partanen, L.; Marttinen, N.; Alatossava, T., Fats and fatty acids as growth factors 
for Lactobacillus delbrueckii. Syst Appl Microbiol 2001, 24, 500-506. 
55. Taoka, Y.; Nagano, N.; Okita, Y.; Izumida, H.; Sugimoto, S.; Hayashi, M., Effect 
of Tween 80 on the growth, lipid accumulation and fatty acid composition of 
Thraustochytrium aureum ATCC 34304. J Biosci Bioeng 2011, 111, 420-424. 
56. Baker, R. C.; Vadehra, D. V.; Gravani, R. B., Neutralization of antimicrobial 
properties of lauricidin by tweens. J Food Safety 1984, 6 (1), 1-12. 
57. Brandl, M. T.; Huynh, S., Effect of the surfactant Tween 80 on the detachment 
and dispersal of Salmonella enterica serovar Thompson single cells and aggregates from 
cilantro leaves as revealed by image analysis. Appl Environ Microbiol 2014, 80 (16), 
5037-5042. 
58. Toutain-Kidd, C. M.; Kadivar, S. C.; Bramante, C. T.; Bobin, S. A.; Zegans, M. 
E., Polysorbate 80 inhibition of Pseudomonas aeruginosa biofilm formation and its 
cleavage by the secreated lipase LipA. Antimicrobial Agents Chemo 2009, 53 (1), 136-
145. 
59. Mireles, J. R.; Toguchi, A.; Harshey, R. M., Salmonella enterica serovar 
typhimurium swarming mutants with altered biofilm-forming abilities: surfactin inhibits 
biofilm formation. J Bacteriol 2001, 183 (20), 5848-5854. 
190 
 
60. Chang, S. T.; Chen, P. F.; Chang, S. C., Antibacterial activity of leaf essential oils 
and their constituents from Cinnamomum osmophloeum. J Ethnopharmacology 2001, 77 
(1), 123-127. 
61. Brackman, G.; Defoirdt, T.; Miyamoto, C.; Bossier, P.; Van Calenbergh, S.; 
Nelis, H.; Coenye, T., Cinnamaldehye and cinnamaldehyde derivatives reduce virulence 
in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response 
regulator LuxR. BMC Microbiol 2008, 8, 149. 
62. Yap, P. S.; Krishnan, T.; Chan, K. G.; Lim, S. H., Antibacterial-mode of action of 
Cinnamomum verum bark essential oil; alone and in combination with piperacillin, 
against a multi-drug-resistant Escherichia coli strain. J Microbiol Biotechnol 2015, 25 
(8), 1299-1306. 
63. Kalia, M.; Yadav, V. K.; Singh, P. K.; Sharma, D.; Pandey, H.; Narvi, S. S.; 
Agarwal, V., Effect of cinnamon oil on quorum sensing-controlled virulence factors and 
biofilm formation in Pseudomonas aeruginosa. PLoS One 2015, 10 (8), e0135495. 
64. Zhang, H.; Dudley, E. G.; Davidson, P. M.; Harte, F., Critical concentration of 
lecithin enhances the antimicrobial activity of eugenol against Escherichia coli. Appl 
Environ Microbiol 2017, 83 (8), e03467-16. 
65. Wilkinson, S. M. The effect of lecithin on inactivation of eugenol of Escherichia 




66. Donsi, F.; Annunziata, M.; Sessa, M.; Ferrari, G., Nanoencapsulation of essential 
oils to enhance their antimicrobial activity in foods. Food Sci Technol 2011, 44, 1908-
1914. 
67. Zhang, H.; Dudley, E. G.; Davidson, P. M.; Harte, F., Critical concentration of 
lecithin enhances the antimicrobial acitivty of eugenol against Escherichia coli. Appl 
Environ Microbiol 2017, 83 (8), e03467-16. 
68. Wickham, M.; Wilde, P.; Fillery-Travis, A., A physicochemical investigation of 
two phosphatidylcholine/bile salt interfaces: implications for lipase activation. BBA 
Molec Cell Biol Lipids 2002, 1580 (2-3), 110-122. 
69. Arnold, G.; Schuldt, S.; Schneider, Y.; Friedrichs, J.; Babick, F.; Werner, C.; 
Rohm, H., The impact of lecithin on rheology, sedimentation and particle interactions in 
oil-based dispersions. Colloids Surfaces A: Physicochem Engineer Aspects 2013, 418, 
147-156. 
70. Taylor, T. M.; Bruce, B. D.; Weiss, J.; Davidson, P. M., Listeria monocytogenes 
and Escherichia coli O157:H7 inhibition in vitro by liposome-encapusalted nisin and 
ethylene diaminetetraacetic acid. J Food Safety 2008, 28 (2), 183-197. 
71. Hollo, J.; Peredi, J.; Ruzics, A.; Jeranek, M.; Erdelyi, A., Sunflower lecithin and 
possibilites for utilization. J American Oil Chemists Society 1993, 70 (10), 997-1001. 
72. Nguyen, H. D. N.; Yang, Y. S.; Yuk, H. G., Biofilm formation of Salmonella 
Typhimurium on stainless steel and acrylic surfaces as affected by temperature and pH 
level. LWT Food Sci Tech 2014, 55 (1), 383-388. 
192 
 
73. Römling, U.; Bian, Z.; Hammar, M.; Sierralta, W.; Normark, S., Curli fibers are 
highly conserved between Salmonella typhimurium and Escherichia coli wih respect to 
operon structure and regulation. J Bacteriol 1998, 180 (3), 722-731. 
74. Costerton, J. W.; Stewart, P. S.; Greenberg, E. P., Bacterial biofilms: A common 
cause of persistent infections. Sci 1999, 284 (5418), 1318-1322. 
75. Molecular Probes LIVE/DEAD BacLight bacterial viability kits. 











Table 4.1. Viable cells recovered from stainless steel discs after being immersed in tryptic soy broth inoculated with S. 
Enteritidis H4267 for various incubation times to grow biofilms, treatment by microemulsions and controls for 5 min, and 
sonication in 0.1% peptone water for 30 s.  
Formulation a  
Viable cells in biofilms grown on stainless steel discs for different times (log10 
CFU/ml) b, c 
0 h 6 h 12 h 18 h 24 h 48 h 
0% SL, 1% CO-OO 
µE 0.0±0.0 B 1.9±0.5 C 5.7±0.3 BC 5.2±0.3 D 5.3±0.4 C 5.3±0.1 BC 
E 0.0±0.0 B 2.6±0.4 C 5.0±0.1 CD 5.7±0.2 C 5.9±0.3 BC 5.4±0.1 BC 
0% SL, 5% CO-OO 
µE 0.0±0.0 B 0.0±0.0 D 2.0±0.3 F 3.6±0.1 F 4.0±0.1 D 4.1±0.3 D 
E 0.0±0.0 B 0.5±0.4 D 4.2±0.1 E 4.6±0.1 E 4.1±0.1 D 4.8±0.4 CD 
2% SL, 5% CO-OO 
µE 0.0±0.0 B 0.0±0.0 D 1.9±0.5 F 3.1±0.2 F 3.1±0.1 E 2.7±0.7 E 
E 0.3±0.5 B 1.8±0.1 B 4.6±0.1 DE 4.2±0.1 E 4.1±0.1 D 4.7±0.2 CD 
0% SL (µE control)  0.0±0.0 B 3.5±0.1 B 6.2±0.4 B 6.5±0.1 B 6.3±0.1 B 6.2±0.2 B 
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Table 4.1 Continued        
2% SL (µE control)  0.6±0.7 B 2.6±0.1 C 4.4±0.0 DE 6.6±0.1 B 6.3±0.1 B 6.1±0.1 B 
No treatment  0.3±0.5 B 1.5±0.1 D 4.8±0.0 F 5.3±0.1 E 5.9±0.0 D 6.0±0.0 CD 
TSB  2.0±0.1 A 5.2±0.3 A 8.7±0.0 A 8.6±0.1 A 8.9±0.0 A 9.0±0.1 A 
a SL = sunflower lecithin, CO-OO = cinnamon oil and orange oil in a 9:1 volume ratio, No treatment = stainless steel disc 
without a treatment, TSB = tryptic soy broth. Microemulsions (µE) were composed of 20% (w/w) Tween 20 and varying 
volumes of deionized water, SL, and oils. Emulsion (E) were composed of 3.3-13.3% (w/w) Tween 80, and varying volumes of 
deionized water, SL, and oils. µE controls (without oil) contained 0 or 2% SL, 20% Tween 20, and varying volumes of 
deionized water.  
b Plate counts are recorded as log10 CFU/ml (N=3). 
 







Figure 4.1. Droplet size diameter of controls containing, on mass basis, 0% or 2% sunflower lecithin (SL), 3.3 to 13.3% 80, 
5% cinnamon oil (CO) and orange oil (OO) in 9:1 volume ratio, and deionized water. The microemulsion controls with 0 or 






















0% SL, 1% CO-OO (9:1), 3.3% Tween 80
0% SL, 1% CO-OO (9:1), 6.7% Tween 80
0% SL, 1% CO-OO (9:1), 13.3% Tween 80
0% SL, 5% CO-OO (9:1), 13.3% Tween 80
2% SL, 5% CO-OO (9:1), 13.3% Tween 80
0% SL, 20% Tween 20 control






Figure 4.2. Zeta-potential of controls containing, on mass basis, 0% or 2% sunflower lecithin (SL), 3.3 to 13.3% Tween 80, 
1 or 5% (w/w) cinnamon oil (CO) and orange oil (OO) in 9:1 volume ratio, and deionized water. The microemulsion 



























0% SL, 1% CO-OO, 3.3% Tween 80
0% SL, 5% CO-OO, 13.3% Tween 80
2% Sl, 5% CO-OO, 13.3% Tween 80
0% SL, 20% Tween 20 control
2% SL, 20% Tween 20 control
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Figure 4.3. S. Enteritidis recovery from emulsion treated biofilms formed on stainless steel discs. Stainless steel discs were 
statically incubated at 37°C in TSB inoculated with S. Enteritidis H4267 until time point collection and discs were exposed to an 






































Biofilm growth time (h)
TSB
Discs without treatment
0% SL, 1% CO-OO microemulsion
0% SL, 1% CO-OO nanoemulsion
0% SL, 5% CO-OO microemulsion
0% SL, 5% CO-OO nanoemulsion
2% SL, 5% CO-OO microemulsion
2% SL, 5% CO-OO nanoemulsion
0% SL, 20% Tween 20 control
2% SL, 20% Tween 20 control
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Chapter 6. Conclusion 
 
Essential oils (EOs) are natural antimicrobials that can be used to develop 
intervention strategies to inhibit pathogens, but EOs are lipophilic. Colloidal systems, 
such as microemulsions, are needed for food industry applications. This dissertation 
focused on the development and characterization of a microemulsion composed of 
cinnamon oil (CO, Cinnamomum zeylanicum) and orange oil (OO, Citrus sinensis) to be 
used against Salmonella Enteritidis H4267 biofilms formed on stainless steel disc 
surfaces.  
The CO was found to have a greater antimicrobial effect on S. Enteritidis H4267 
when used in combination with OO than when used individually (p<0.001). The 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) indicated that CO and OO were optimum in a 9:1 volume ratio (MIC and MBC: 
750: 750 ppm) compared to a 1:1 volume ration (MIC and MBC: 1250: 750 ppm). 
Physical analyses determined that, on mass basis, 0% and 2% sunflower lecithin (SL), 
20% Tween 20, 1% and 5% CO-OO (9:1) formulations were transparent, 
thermodynamically stable, and Newtonian fluids. These formulations were determined to 
be microemulsions and demonstrated bactericidal activity on S. Enteritidis H4267.  
The second objective investigated the biofilm forming ability of S. Enteritidis 
H4267 and determined a biofilm removal method for biofilms on stainless steel disc 
surfaces. Microtiter assays demonstrated biofilm formation on microtiter cell walls as 
early as 6 h of incubation at 37°C with CV solubilization demonstrating that biofilm 
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formation increased over 48 h. Rinsing three times prior to sonication in 0.1% (w/v) 
peptone water removed planktonic cells from disc surfaces while also effectively 
dislodging biofilms. Sonication at 25% power (5 kHz) for 30 sec and 1 min was shown to 
dislodge S. Enteritidis H4267 cells and/or clusters from disc surfaces without causing 
extensive cell death. The 30 sec sonication time was selected as it was a shorter 
sonication time and did not differ from 1 min sonication in terms of S. Enteritidis H4267 
recovery.  
When microemulsions were used to treat S. Enteritidis H4267 biofilms formed on 
stainless steel discs for 5 min, only the formulations with CO-OO at levels above 1% 
showed antimicrobial activity. The microemulsions composed of 2% SL, 5% CO-OO, 
and 20% Tween 20 had the highest antimicrobial activity against S. Enteritidis H4267 
biofilms formed on stainless steel discs, showing consistent activity over 48 h and higher 
activity than a nanoemulsion control with bigger droplets. Due to the limitations of time 
points tested, determining whether emulsion size or surfactant addition affected 
antimicrobial ability the most was not determined.  
Despite limitations, this study proves that microemulsions composed of CO-OO 
can serve as an antimicrobial delivery system against S. Enteritidis H4267, either as 
planktonic cells or as biofilms present on stainless steel surfaces. Co-encapsulating EOs 
in microemulsions could be further developed for loading capacity and activity of EO 
antimicrobial delivery systems. Further research into developing microemulsions with 
positively charged droplets and exposing biofilms to microemulsions for longer times 
should be investigated. Additional methods, such as scanning electron microscopy, viable 
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versus non-viable cell identification, and fluorescence microscopy, should also be 
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